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ZUSAMENFASSUNG 1
1 Zusammenfassung 
Polysialinsäure (polySia, poly-α2,8-N-acetylneuraminic acid) ist eine dynamisch regulierte 
posttranslationale Modifikation des Neuralen Zelladhäsionsmoleküls NCAM. Polysialyliertes NCAM 
ist ein wichtiger Promotor zellulärer Plastizität im sich entwickelnden embryonalen und im adulten 
Gehirn. PolySia ist an der Steuerung zahlreicher neuronaler Prozesse wie Migration, axonalem 
Wachstum und Wegfindung, synaptischer Aktivität bis hin zu Lern- und Gedächtnisleistungen und 
schließlich an der Neurogenese beteiligt. Darüber hinaus ist polySia ein Marker für verschiedene 
aggressive Tumore neuroectodermalen Ursprungs und ein bedeutender Virulenzfaktor neuroinvasiver 
Bakterien, die Sepsis und Meningitis verursachen. Es wird postuliert, dass die antiadhäsiven 
Eigenschaften der polySia, resultierend aus Größe und Ladung des Polysaccharids, für die zahlreichen 
Funktionen verantwortlich sind.  
Die Expression von polySia in Tumoren korreliert mit hohem Metastasierungspotential und einer 
schlechten Prognose. Man nimmt heute an, dass polySia die Ablösung einzelner Zellen vom 
Primärtumor erleichtert und die Halbwertszeit der Tumorzellen in der Zirkulation erhöht, da 
tumorspezifische Antigene durch die immunologisch inerte polySia abgeschirmt werden.  
Mit Blick auf das Ziel, steuernd in die polySia Expression einzugreifen, stellen die Schlüsselenzyme 
der NCAM-Polysialylierung, die Polysialyltransferasen ST8SiaII und ST8SiaIV, vielversprechende 
Zielstrukturen dar. Eine für die Entwicklung therapeutisch wirksamer Substanzen zwingend 
notwendige biochemische und strukturelle Charakterisierung dieser Enzyme steht jedoch noch 
weitgehend aus. Der wichtigste Grund hierfür ist die begrenzte Verfügbarkeit der 
Polysialyltransferasen. Polysialyltransferasen sind Glykoproteine und die Funktion der Enzyme ist 
essentiell an die Integrität der Glykosylierung gebunden. Somit ist die rekombinante Herstellung 
aktiver Polysialyltransferasen nur in glycosylierungskompetenten Zellsystemen möglich. Im Verlauf 
dieser Arbeit wurde ein System zur Expression und Aufreinigung von eukaryotischen 
Polysialyltransferasen in einem Insektenzellsystem (Sf9) etabliert. Die Studien wurden modellhaft für 
die Polysialyltransferase ST8SiaIV durchgeführt. Über diverse Optimierungsschritte wurde die 
Expression und homogene Darstellung des aktiven Proteins im Milligrammbereich erreicht. Mit dem 
gereinigten Enzympool wurden ausgedehnte Versuchsreihen zur Kristallisation des Proteins 
durchgeführt. Allerdings konnten bislang keine Proteinkristalle erhalten werden.  
In einem zweiten Projekt wurden Studien zur Aufklärung von Struktur- und 
Funktionszusammenhängen polySia degradierender Enzyme, der Endoneuraminidasen, unternommen. 
Endoneuraminidasen sind Bakteriophagenproteine und die einzigen bisher bekannten Enzyme, die 
hoch spezifisch polySia abbauen. Sie sind im Zusammenhang mit Diagnose und Therapie polySia 
positiver Tumore von großem Interesse. Im Rahmen dieser Arbeit gelang erstmals die Kristallisation 
und strukturelle Analyse einer Endoneuraminidase. Die katalytisch aktive Einheit der 
Endoneuraminidase des Phagen K1F wurde bestimmt und im Komplex mit oligomerer Sialinsäure 
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kristallisiert. Das Enzym setzt sich aus vier klar unterscheidbaren Domänen zusammen. Die aktive 
Einheit ist das Trimer, das eine Pilz-ähnliche Struktur ausbildet. Dabei enthält der „Schirm“ 
Strukturelemente die auch in Exosialidasen gefunden werden, während das dominierende 
Strukturmotive des „Stiels“ eine Tripel-β-Helix ist. Die erhaltenen Kristallstrukturdaten zeigen klar, 
dass pro Trimer drei polySia Ketten binden, wobei die Bindung jeder einzelnen polySia Kette alle drei 
im funktionellen Komplex vorhandenen Untereinheiten verlangt. Die Struktur des aktiven Zentrums 
und der Bindungsmodus des Substrates lassen auf einen substratvermittelten Katalysemechanismus als 
molekulare Basis für die hohe Subatratspezifität der Endoneuraminidasen schließen. 
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2 Abstract 
Polysialic acid (polySia, poly-α2,8-N-acetylneuraminic acid) is a dynamically regulated 
posttranslational modification of the neural cell adhesion molecule (NCAM). Polysialylated NCAM is 
an important mediator of cellular plasticity in the developing and in the adult brain. PolySia has been 
implicated in many neuronal processes like neurogenesis, cell migration, axonal growth and 
pathfinding and synaptic activity including learning and memory.  Moreover, polySia is an 
oncodevelopmental marker expressed by several aggressive tumours of neuroectodermal origin and an 
important virulence factor of pathogenic bacteria causing sepsis and meningitis. It is proposed that 
many of the biological functions of polySia result form its anti-adhesive properties caused by size and 
charge of the polysaccharide.   
The expression of polySia in tumours directly correlates with poor prognosis and high metastatic 
potential. PolySia is believed to facilitate the shedding of cells from primary tumours and to protect 
metastatic cells in the circulation by hiding tumour specific antigens from the immune system. Main 
targets to interfere with polySia expression are the key enzymes of the polysialylation pathway, the 
eukaryotic polysialyltransferases ST8SiaII and ST8SiaIV. However, detailed structural and 
biochemical characterisations of the enzymes, essential for the development of therapeutic substances, 
were heretofore prevented mainly by very limited protein supply. Polysialyltransferases are 
glycoproteins and the integrity of the glycosylation is pivotal for enzymatic activity. Therefore 
recombinant production of polysialyltransferases requires glycosylation competent cell systems.  In 
the course of this study an expression and purification procedure was established using an insect cell 
system (Sf9 cells). The studies were exemplary carried out with the polysialyltransferase ST8SiaIV. 
After careful optimisation of expression and purification conditions several milligrams of 
homogeneously purified enzyme were obtained. The purified enzyme was used for extensive 
screenings in crystallisation experiments, however, no protein crystals were observed so far.   
The second project of this study concentrated on delineating the structure-function relationships of 
polySia degrading enzymes, the endoneuraminidases. These phage born proteins are the only known 
enzymes that specifically degrade polySia.  They are of particular interest with respect to diagnosis or 
therapy of polySia bearing human tumours. This study describes the first crystal structure of an 
endoneuraminidase. Crystals were obtained of the catalytic domain of endoneuraminidase of 
bacteriophage K1F (amino acids 246-911) in complex with oligomeric sialic acid. The enzyme folds 
into four distinct domains and assembles into a catalytic trimer with an overall mushroom like outline. 
The ‘cap’ domain contains structural elements also found in exosialidases while the dominant 
structural feature of the ‘stem’ region is a triple β-helix. The obtained data clearly show, that each 
trimer can bind and hydrolyse three polySia chains, whereby the binding of each polySia chain 
requires all three subunits of the functional complex. The structure of the active site and the mode of 
polySia binding suggest a substrate assisted catalytic mechanism as molecular basis for the high 
substrate specificity of endoneuraminidases.  
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3 Introduction 
3.1 Polysialic acid 
Linear homopolymers of sialic acids represent unique carbohydrate structures that have been 
identified in a broad evolutionary range of species from bacteria to humans.  Polysialic acid 
has been detected in neuroinvasive bacteria, fish and sea urchin eggs, Drosophila embryos as well 
as in vertebrate tissues (Mühlenhoff et al., 1998). Although more than 50 distinct sialic acid 
derivatives have been described, in polysialic acids mainly 5-N-acetylneuraminic acid 
(Neu5Ac), 5-N-glycolylneuraminic acid and 2-keto-3-deoxynonulosonic acid (Kdn) are found 
(Figure 1). 
 
Figure 1: Three major building blocks of polysialic acid: 5-N-acetylneuraminic acid (Neu5Ac), 5-N-
glycolylneuraminic acid and 2-keto-3-deoxynonulosonic acid (Kdn) 
 
Already the unusual binding properties of polySia specific antibodies and enzymes, requiring 
at least an octamer of α2,8-linked sialic acid residues for efficient binding, have lead to the 
postulation of an extended binding epitope formed by the polysaccharide chains (Finne and 
Makela, 1985; Jennings et al., 1985; Evans et al., 1995) and NMR studies with polySia 
derived from encapsulated bacteria provided evidence for high-order local helices with an 
extended conformation of approximately nine residues per turn (Brisson et al., 1992).  A most 
recent NMR study, however, was unable to confirm the helical conformation (Henderson et 
al., 2003). It may be that the polySia concentration used in these studies provides a crucial 
factor for the secondary organisation of the chain.  
Due to the carboxylate function in position C2 sialic acids are negatively charged under 
physiological conditions. The polyanionic polySia has been shown to possess a high water 
binding capacity and thus a large hydrodynamic volume (Yang et al., 1992). Experiments 
have been carried out to define the length of the polySia chains in bacteria and vertebrates. 
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Although no precise numbers are available, the obtained data demonstrate that polySia chains 
in bacteria reach up to 200 residues (Rohr and Troy, 1980) while the degree of polymerisation 
(dp) is significantly smaller in vertebrates (dp ≤ 60; (Inoue et al., 2000; Angata et al., 2002)).  
Expression of the bulky, space filling polySia in vertebrate tissues has been suggested to 
attenuate cellular interactions and plays a critical role in many developmental processes. Of 
particular interest is also the reexpression of polySia on human tumours including Wilms’ 
tumour (Roth et al., 1988), small cell lung carcinoma (Kibbelaar et al., 1989; Komminoth et 
al., 1991), neuroblastoma (Livingston et al., 1988; Figarella-Branger et al., 1990) and 
rhabdomyosarcoma (Soler et al., 1993). In these tumours polySia expression has been 
correlated with poor prognosis and was shown to increase metastatic potential and tumour 
growth (Scheidegger et al., 1994; Glüer et al., 1998; Tanaka et al., 2000; Daniel et al., 2001).   
Moreover, polySia capsules provide important virulence factors of neuroinvasive bacteria 
causing sepsis and meningitis in humans.  
 
3.2 Polysialic acid in mammals 
To date, a total of three polysialylated proteins have been identified in mammals. By far the 
major carrier of polySia is thereby the neural cell adhesion molecule (NCAM). Knock out 
mice lacking NCAM (Cremer et al., 1994), have been described to be devoid of polySia. 
However, polySia has also been identified on the α-subunit of the voltage depended sodium 
channel (Zuber et al., 1992) and the CD36 scavenger receptor in milk (Yabe et al., 2003). 
 
3.2.1  The Neural Cell Adhesion Molecule (NCAM) 
NCAM is a membrane bound glycoprotein that belongs to the family of immunoglobuline-
like proteins. NCAM contains five immunoglobuline (Ig)-like domains and two fibronectin 
type III repeats. NCAM is schematically shown in Figure 2. 
 
INTRODUCTION 6
 
Figure 2: Schematic representation of the neural cell adhesion molecule (NCAM) The N-terminal part 
contains five immunoglobuline-like domains indicated with latin numbers (I-V) and two fibronectin type III 
repeats (FNIII). Out of six N-glycosylation sites present in the NCAM only two (sites five and six) can be 
modified with polySia.  
 
NCAM exists in three major isoforms of 180, 140 and 120 kDa that arise from alternative 
splicing of a single gene located on human chromosome 11 (Hirn et al., 1983; Walsh et al., 
1986; Cunningham et al., 1987; Santoni et al., 1987; Barthels et al., 1987; Santoni et al., 
1989). The three isoforms have identical N-terminal domains but differ with respect to their 
cytoplasmic tails and their association to the membrane. NCAM 180 and 140 both are 
membrane spanning proteins with C-terminal cytosolic domains of differing size while 
NCAM 120 is linked to the membrane by a glycosyl-phosphatidylinositol anchor (He et al., 
1987). Six N-glycosylation sites are present in NCAM, but polySia is selectively added to 
sites 5 and 6 of the fifth immunoglobulin-like domain (Nelson et al., 1995; Liedtke et al., 
2001; Von der Ohe et al., 2002). Recent analysis of the polysialylated N-glycans of murine 
NCAM revealed bi-, tri- and tetraantenary complex-type core structures that were partially 
sulphated (Liedtke et al., 2001). 
 NCAM is an important mediator of cellular interactions and was first characterised as 
calcium independent homophilic adhesion molecule. The third Ig-like domain of NCAM was 
assigned to mediate the trans-binding interactions between NCAM molecules of adjacent 
cells (Rao et al., 1992). Furthermore interactions with extracellular matrix proteoglycans via 
the second Ig-like domain were reported (Cole et al., 1986) and heterophilic cis-interactions 
of NCAM with the cell adhesion molecule L1 were described. Here the fourth Ig-like domain 
of NCAM was proposed to bind to oligomannosidic structures expressed by L1 (Kadmon et 
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al., 1990a; Kadmon et al., 1990b; Horstkorte et al., 1993). In addition, the largest isoform 
NCAM 180, but not the smaller isoforms (NCAM 120 and NCAM 140), was shown to make 
contacts to the cytoskeleton by binding to brain spectrin (Pollerberg et al., 1986; Pollerberg et 
al., 1987).  
Like other adhesion molecules also NCAM directly participates in cell signalling pathways. 
Most recently NCAM 140 was shown to be an alternative signalling receptor for glial cell 
line-derived neurotrophic factor (GDNF) family ligands (Paratcha et al., 2003). Association 
of NCAM with GFRα1 as coreceptor was shown to enhance GDNF binding and result in a 
rapid activation of fyn (Paratcha et al., 2003). Constitutive association of NCAM 140 with the 
cytoplasmic tyrosine kinase fyn had already been described in earlier studies to recruit the 
focal adhesion kinase FAK (Beggs et al., 1997). In other studies NCAM was reported to 
transactivate the fibroblast growth factor receptor (FGFR) (Williams et al., 1994; Saffell et 
al., 1997).  
PolySia is a prominent posttranslational modification of NCAM and strongly influences the 
functions of the protein. The negatively charged and highly hydrated polysaccharide is 
supposed to exhibit a strong anti-adhesive effect and thus interfere with the overall formation 
of tight cell-cell contacts. In the neural system, the presence of polySia strictly correlates with 
stages of cellular motility and/or functional plasticity (Rutishauser and Landmesser, 1996).  
The expression of polySia is developmentally regulated and found at highest levels in 
embryonic and neonatal stages where it is not only restricted to neural tissues but also 
expressed in developing kidney, heart or skeletal muscles (Finne et al., 1983; Sunshine et al., 
1987). Polysialylated NCAM is involved in a number of developmental events such as cell 
migration (Ono et al., 1994) or axonal growth and fasciculation (Doherty et al., 1990; Zhang 
et al., 1992). In the adult, expression of polySia is restricted to brain areas with ongoing 
neurogenesis and plasticity including the olfactory bulb (Miragall et al., 1990), the 
hypothalamus (Theodosis et al., 1991) and the hippocampus (Seki and Arai, 1991; Bonfanti et 
al., 1992). PolySia found in the suprachismatic nuclei (SCN) of the hypothalamus was shown 
to impair circardian rhythm stability and attenuate photic signalling events (Shen et al., 1997; 
Glass et al., 2000). Presence of polySia in the hippocampus was found to be required for the 
induction of long-term potentiation (LTP) (Muller et al., 1996) and was associated with 
learning and memory processes (Becker et al., 1996). As the hippocampal expression of 
polySia is regulated by neuronal activity (Muller et al., 1996) polySia was proposed to 
function as activity-induced modulator of synaptic plasticity (Kiss and Rougon, 1997).   
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The model introduced by Rutishauser (Rutishauser, 1996) explains the broad range of 
biological effects of polySia with impeding sterical influences of the bulky structure on cis- 
and trans- binding interactions. According to this model, polySia does not only influence 
NCAM-mediated binding functions, but has a general effect on cellular contact formation. 
There is, however, growing evidence that besides the mode of action by sterical hindrance, 
polySia has other biological activities. It has for instance been shown that polySia is required 
to obtain sensitivity of neurons towards the brain-derived neurothrophic factor (BDNF) 
(Vutskits et al., 2001). 
 
3.2.2 Eukaryotic polysialyltransferases 
Two polysialyltransferases, ST8SiaII and ST8SiaIV, that add polysialic acid to NCAM have 
been cloned from several vertebrate species (Livingston and Paulson, 1993; Eckhardt et al., 
1995; Yoshida et al., 1995; Nakayama et al., 1995; Scheidegger et al., 1995). Both enzymes 
are typ-II transmembrane proteins and with 59% identity at amino acid level highly 
homologous to each other (Figure 3). They contain three sequence motifs known as 
sialylmotifs L (large), S (short) and VS (very short) that are conserved in all eukaryotic 
sialyltransferases (Livingston et al., 1993; Drickamer, 1993; Geremia et al., 1997). 
Mutagenesis studies of the α2,6-sialyltransferase ST6GalI provided convincing evidence that 
the L-motif is involved in binding of the sugar donor CMP-Neu5Ac, while the S-motif 
participates in the binding of both, donor and acceptor substrate (Datta and Paulson, 1995; 
Datta et al., 1998). Mutations of the two conserved VS-motif residues (HxxxxE) resulted in 
inactive but secreted ST8SiaIV mutants illustrating the functional importance of this short 
motif (Windfuhr et al., 2000; Kitazume-Kawaguchi et al., 2001)  
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Figure 3: Schematic representation of polysialyltransferases  (A) Cartoon illustrating the typ II membrane 
topology; transmembrane domain (TMD), stem region and globular catalytic domain are indicated. (B) 
Schematic representations of ST8SiaII and ST8SiaIV. The large (L) and the small (S) sialylmotifs are 
highlighted as black boxes, the position of the very short sialylmotifs (VS) is indicated by arrows. Asparagine 
residues involved in N-glycosylation are indicated. N-glycans important for polysialyltransferase activity are 
marked with filled circles.  
 
ST8SiaII and ST8SiaIV are both individually able to polysialylate all NCAM-isoforms by 
adding polySia to complex α2,3- or α2,6- sialylated N-glycans (Mühlenhoff et al., 1996b; 
Angata et al., 1998; Franceschini et al., 2001). Both poloysialyltransferases prefer the sixth 
(membrane proximal) N-glycosylation site of NCAM (Figure 2); although this effect is less 
pronounced in the case of ST8SiaII (Angata et al., 1998). Both enzymes polysialylate glycan 
structures attached to NCAM with much greater efficiency than N-glycans released from 
NCAM (Angata et al., 2000), suggesting that the polysialylation reaction is protein specific. 
Recent in vivo cell culture studies with NCAM deletion mutants showed, that the fifth Ig-like 
domain and the adjacent fibronectin type III (FN) repeat are sufficient for polysialylation by 
both enzymes. Thereby, the FN repeat seems to act as polysialyltransferase recognition and 
docking site (Close et al., 2003). This finding contrasts earlier in vitro data were also the 
fourth Ig-like domain of NCAM was found to be crucial for polysialylation (Angata et al., 
2002). 
In vitro ST8SiaIV was shown to produce longer polySia chains than ST8SiaII (Angata et al., 
1998; Windfuhr et al., 2000; Mühlenhoff et al., 2001; Angata et al., 2002) and to exhibit a 
wider acceptor spectrum. In contrast to ST8SiaII, it was able to extend oligosialylated 
monoantennary structures and to polysialylate more than one antenna of multiantennary core 
structures (Angata et al., 2002). The same authors also reported that the concerted action of 
both enzymes resulted in more and longer polySia chains then seen with either enzyme alone 
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(Angata et al., 2002) and proposed that ST8SiaII and IV act cooperatively in NCAM 
polysialylation.  
 
Besides the polysialylation of NCAM the protein specific polysialyltransferases were shown 
to modify themselves by adding polySia onto their own N-glycans. This self modification, 
referred to as autopolysialylation, was described for both enzymes in vitro and in vivo 
(Mühlenhoff et al., 1996a; Close and Colley, 1998; Mühlenhoff et al., 2001). The 
polysialyltransferases contain six (ST8SiaII) and five (ST8SiaIV) N-glycan attachment sites, 
respectively. Autopolysialylation is predominantly involving the N-glycan attached to 
asparagine 74 in ST8SiaIV and the N-glycans attached to asparagines 89 and 219 in ST8SiaII 
(Mühlenhoff et al., 2001). In contrast to NCAM-polysialylation, where priming sialylation in 
α2,3- or an α2,6- glycosidic linkage is the minimal requirement for polySia synthesis 
(Mühlenhoff et al., 1996b; Angata et al., 1998), autopolysialylation can occur on asialo-
glycans but was shown to require terminal galactose. Agalacto forms of ST8SiaIV are unable 
to perform auto- and NCAM-polysialylation (Mühlenhoff et al., 1996a). This argues for a 
tight functional link between NCAM- and autopolysialylation, however, the hypothesis that 
an en bloc transfer of autocatalytically synthesized polySia chains to the acceptor NCAM 
occurs, could be ruled out (Mühlenhoff et al., 1996a). Whether the self-modification process 
is in fact a prerequisite for functional polysialyltransferases or whether autopolysialylation 
has only enhancing influence on NCAM-polysialylation is controversially discussed and the 
reported data are partly contradicting (Close et al., 2000; Windfuhr et al., 2000; Angata et al., 
2001; Mühlenhoff et al., 2001; Close et al., 2001) 
Transcript analyses revealed that both polysialyltransferases are expressed in early 
developmental stages, but ST8SiaII is the prominent enzyme in embryonic tissue and its 
transcript level decreases substantially after birth. In the adult brain ST8SiaIV is the dominant 
enzyme (Angata et al., 1997; Hildebrandt et al., 1998; Ong et al., 1998). Consequently very 
low polySia levels were detected in adult ST8SiaIV-deficient mice and an age-dependent 
impairment of learning and memory was shown via reduced long-term potentiation and long-
term depression (Eckhardt et al., 2000).  
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3.3 Endoneuraminidases 
Bacteriophage-born endoneuraminidases (endoN) have been essential and widely used tools 
in polySia research and to a large extend enabled the recent progress made in understanding 
the physiological and pathological functions of polySia. Endoneuraminidases are the only 
enzymes known so far that efficiently degrade polySia. As they are highly specific for 
polysialic acid, the enzymes can be used to exclusively degrade polySia on cultured cells or 
even in living animals without interfering with abundant monosialylated structures.  
Endoneuraminidases have been isolated from bacteriophages capable to infect polySia 
encapsulated E. coli K1. This neuroinvasive pathogen, which causes sepsis and meningitis in 
neonates wears a thick layer of α2,8-linked sialic acid residues (Figure 4) composed of up to 
200 residues per chain (Rohr et al., 1980). The polySia capsule is an important virulence 
factor of the pathogenic bacterium. It is structurally and immunochemically identical to 
polySia found in the human host, enabling the bacterium to escape the human immune system 
by ‘antigenic mimicry’. Identical capsules are also found in the human pathogen Neisseria 
meningitidis serogroup B, in Moraxella nonliquefaciens and in Pasteurella haemolytica A2 
infecting ruminants (Troy, 1992). Capsules composed of alternating α2,8/α2,9-linked sialic 
acid residues are described for E. coli K92 and Bos-12 strains while Neisseria meningitidis 
serogroup C capsules consits of α2,9-linked sialic acids. In accordance with the ‘antigenic 
mimicry’ concept, α2,8-linked capsular polysaccharides are poorly immunogenic, while the 
capsules containing also α2,9-linkages induce massive immune reactions in the host. 
Though polysaccharide capsules generally protect bacteria from hostile environmental 
influences, many encapsulated bacterial are infected by specialized bacteriophages that carry 
host-capsule degrading hydrolases. These enzymatic activities enable the phages to penetrate 
the protective capsular layer and access the bacterial membrane (Figure 4). The hydrolases are 
usually tailspike associated and important determinants of the bacteriophage host range. 
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Figure 4: PolySia encapsulated E. coli K1 (A) Electron microscopy of an E. coli K1 bacterium encapsulated in 
polysialic acid (Roth et al., 1993). The thick polySia capsule is seen as amorphous grey layer surrounding the 
bacterium. (B) Schematic representation of bacteriophages penetrating the polySia capsule of E. coli K1. 
 
More than 20 bacteriophages have so far been isolated mainly from sewage that specifically 
infect E. coli K1 (Table 1). The K1-specific phages are lytic linear double-stranded DNA 
viruses of different morphology. Tough most of the phages belong to the group of 
podoviridae with short noncontractile tails, some were shown to be myoviridae exhibiting a 
long and contractile tail apparatus (Miyake et al., 1997). Common to all K1-phages are 
polySia degrading tailspikes, the endoneuraminidases, that were shown to be associated with 
the bacteriophage baseplate (Petter and Vimr, 1993; Miyake et al., 1997).   
 
phage host  strain phage isolation endosialidase gene enzyme 
ΦK1A, ΦK1B, 
ΦK1C, ΦK1D, 
E. coli K1 (Gross et al., 1977) -  
ΦK1E E. coli K1 (Gross et al., 1977) (Gerardy-Schahn et al., 1995) 
(Long et al., 1995) 
endoNE 
ΦK1F E. coli K1 (Vimr et al., 1984) (Petter et al., 1993) 
(Mühlenhoff et al., 2003) 
endoNF 
Φ 1.2 E. coli K1 (Kwiatkowski et al., 1982) -  
B, C, D, F, G, K, L, 
P, R 
E. coli K1 (Smith and Huggins, 1982) -  
3, 9, a, d, A, E E. coli K1 (Miyake et al., 1997) -  
63D E. coli K1 (Machida et al., 2000) Accession Nr. AB015437 endoN63D 
ΦK1-5 E. coli K1            
E. coli K5 
(Scholl et al., 2001) (Scholl et al., 2001)  
Φ 92 E. coli K1             
E. coli K92 
(Kwiatkowski et al., 1983) -  
Table 1: Overview of  isolated E. coli K1 specific phages and cloned endoneuraminidase genes  
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A common cleavage pattern was reported for the endosialidases of ΦK1A – E and Φ92 by 
analysing the purified phages. For moderate enzyme and high substrate concentrations the 
minimum substrate size was found to be an octamer of sialic acid residues that was cleaved 
five residues from the reducing end (Pelkonen et al., 1989). However, the same study reported 
under exhaustive conditions (high enzyme concentrations) further enzyme specific break 
down of the substrate. Similar studies performed with endoN purified from ΦK1F reported a 
minimum of five sialic acid residues for cleavage yielding mainly tetrameric and monomeric 
sialic acid (Hallenbeck et al., 1987). All endoneuraminidases purified from phage lysates 
were shown to oligomerise. EndoNF forms SDS-resistant homotrimers composed of 103 kDa 
subunits (Hallenbeck et al., 1987; Mühlenhoff et al., 2003), while for endoNE an SDS-
resistant heterotrimeric complex with a not further characterised 38 kDa protein was 
described (Tomlinson and Taylor, 1985; Gerardy-Schahn et al., 1995). EndoN63D was 
reported to form tetrameric complexes composed of 90 kDa subunits linked by disulfide 
bridges.  
Meanwhile endoneuraminidases have been cloned from the phages K1E, K1F, 63D and K1-5 
(Petter et al., 1993; Gerardy-Schahn et al., 1995; Long et al., 1995; Machida et al., 2000; 
Scholl et al., 2001; Mühlenhoff et al., 2003), whereby the enzymes cloned from ΦK1E and 
ΦK1-5 are almost identical (>97% amino acid identity). All enzymes share a common endoN 
core domain of about 650 amino acids with high sequence identity (50-81 %) that was 
proposed to harbour the catalytic domain. In contrast to endoNE, the significantly larger 
endosialidases cloned form ΦK1F and Φ63D are N-terminally extended by 200 and 120 
amino acids, respectively. The extended regions exhibit homology to the N-terminal part of 
the tail fibre protein gp17 of coliphages T3 and T7 and of yersiniophage YeO3-12 (Pajunen et 
al., 2000). For coliphage T7 was shown that complexes of gp17 form the phage tail fibres and 
that the fibres are attached to the phage capsid by the N-terminal domain of gp17 (Steven et 
al., 1988). Thus a similar function of the homologous region in endoNF and endoN63D has 
been suggested (Petter et al., 1993). 
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Figure 5: Schematic representation of the cloned endoneuraminidases The highly homologous endoN core 
domain is highlighted in grey. The sites of proteolytic cleavage are indicated by arrows while homologous 
stretches within the C-terminal domain are shown as black bars. The C-terminal domain exhibits sequence 
similarity to the C-terminal parts of the neck appendage protein gp12 of Bacillus subtilis phage GA-1, the 
L-shaped tail fiber protein (LTF) of coliphage T5 and to K5-specific lyases of coliphages  K5 und K1-5 as well 
as to the E. coli K5 lyase. The N-domains of endoN63D and endoNF exhibit homology to parts of the tail fibre 
protein gp17 of coliphages T3 and T7 and of yersiniophage YeO3-12. 
 
Recently it was shown, that the C-terminal domain of endoNE and endoNF is proteolytically 
cleaved off during maturation of the enzymes (Leggate et al., 2002; Mühlenhoff et al., 2003). 
The conserved cleavage site is indicated by arrows in Figure 5. Cleavage is not essential for 
activity and the cleaved off domain is not part of the active enzyme complex (Mühlenhoff et 
al., 2003). However, the presence of this domain in the primary translation product was 
demonstrated to be a prerequisite for the formation of active endosialidases suggesting that 
the C-terminal domain facilitates proper folding or complex formation of the enzymes 
(Mühlenhoff et al., 2003). Database searches revealed significant homology between the C-
terminal part of the endosialidases and other phage tail proteins (see Figure 5) (Mühlenhoff et 
al., 2003). Whether these domains have a similar function and the presence of an 
intramolecular ‘chaperone’ or ‘oligomerisation platform’ is a more common concept in tail 
associated bacteriophage proteins remains to be elucidated. 
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3.4 Aims of the present study 
Polysialic acid is an important modulator of cellular interactions essentially involved in 
ontogenic development and integrity of neuronal functions. Ectopic expression of polySia has 
been associated with severe human diseases, e.g. neuroendocrine tumours. In addition, 
polySia is an important virulence factor of pathogenic bacteria causing sepsis and 
meningitides. The key enzymes in polySia synthesis are the polysialyltransferases. Genes 
encoding polysialyltransferases have been cloned from different vertebrate sources and from 
the neuroinvasive bacteria E. coli K1 and Neisseria meningitides. Because 
polysialyltransferases are the main targets to interfere with the cellular polysialylation 
machinery, the goal of the study was to delineate molecular details on structure-function-
relationships in this enzyme group. Towards this aim my studies concentrated on the large 
scale expression and purification of eukaryotic polysialyltransferases to enable structural 
analyses by protein crystallization  
My second project concentrated on polySia degrading enzymes, the endoneuraminidases. 
Endoneuraminidases are the only known enzymes that specifically bind and degrade 
polysialic acid and therefore are widely used tools in polySia research. Most recent studies in 
animal model systems highlighted the therapeutic potential of these enzymes by 
demonstrating that endoneuraminidase activity interfered with the pathomechanism of 
neuroinvasive bacteria and limited the metastatic potential of polySia encapsulated tumour 
cells. Because no information was available on the functional mechanisms of endosialidases 
when this study was started, my second goal pointed towards the molecular characterisation 
of endoneuraminidases by crystal structure analysis. 
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4 Materials and methods 
4.1 Materials 
4.1.1 Cell lines 
Sf9 cells : Spodoptera frugiperda insect cell line (Invitrogen) 
CHO-2A10 : Chinese hamster ovary cell line with defect ST8SiaIV gene 
(Eckhardt et al., 1995) 
CHO-6B2 : Chinese hamster ovary cell line with defect CMP-sialic acid 
transporter gene (Eckhardt et al., 1996) 
 
4.1.2 Bacterial strains 
E. coli JM109 :  Genotype: e14-(McrA-) recA1 endA1 gyrA96 thi-1 hsdR17(rk- mk+) 
supE44 relA1 ∆(lac-proAB) [F‘ traD36 proAB laclqZ∆M15] 
(Stratagene) 
E. coli DH10Bac : Genotype: F- mcrA (mrr-hsdRMS-mcrBC) 80dlacZM15 lacX74 
deoR recA1 endA1 araD139 (ara-leu)7697 galU galK rpsL nupG 
/bMON14272 /pMON7124 (Invitrogen) 
E. coli BL21(DE3)  : Genotype: F- ompT hsdSB (rB- mB-) gal dcm (DE3) (Novagen) 
E. coli B834(DE3)  : Genotype: F- ompT hsdS6 (rB- mB-) gal dcm met (DE3) (Novagen) 
 
4.1.3 Plasmids 
pProtA-PST :  Eukaryotic expression vector for expression of soluble and secreted 
N-terminally by 25 amino acids truncated ST8SiaIV as protein A 
fusion protein  (Mühlenhoff et al., 2001). 
pMyc-ST8SiaIV : Eukaryotic expression vector for expression of soluble and secreted 
N-terminally by 25 amino acids truncated ST8SiaIV with C-
terminal myc-His6-epitope (Windfuhr et al., 2000). 
pFastBac-HBM : Baculovirus transfer vector based on pFastBac (Invitrogen) 
including a honey-Bee melittin (HMB) secretion signal (obtained 
from Y.Strandberg, IMB, Bisbane, Australia). 
pFastBac-HT : Baculovirus transfer vector of the Bac-To-Bac system (Invitrogen). 
Includes His6-tag and rTev-protease site.  
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pHBM∆25-ST8SiaIV : Transfer vector used to generate recombinant baculovirus for 
expression of C-terminally myc-His6-tagged ST8SiaIV secreted to 
the culture medium of Sf9 cells. The N-terminally by 25 amino 
acids truncated ST8SiaIV was amplified from pMyc-ST8SiaIV  
(including the myc-His6-sequence) using the primer pair KS1f/KS1r 
and inserted between restriction sites XhoI and HindIII of pFastBac-
HBM. 
pFB∆25-ST8SiaIV : Transfer vector used to generate recombinant baculovirus for 
expression of  N-terminally His6-tagged ST8SiaIV in Sf9 cells. The 
N-terminally by 25 amino acids truncated ST8SiaIV was amplified 
from pMyc-ST8SiaIV (without myc-His6-sequence) using the 
primer pair MM35/KS9r and inserted between restriction sites NcoI 
and HindIII of pFastBac-HT.  
pHBMHT∆25-ST8SiaIV : Transfer vector used to generate recombinant baculovirus for 
expression of  N-terminally His6-tagged ST8SiaIV secreted to the 
culture medium of Sf9 cells. The ST8SiaIV-insert of pFB∆25-
ST8SiaIV (including His6-rTev-sequence) was amplified using the 
primer pair KS15/KS9r and inserted between restriction sites SacI 
and HindIII of pFastBac-HBM.  
pET22b-Strep :  Prokaryotic expression vector based on pET22b (Novagen) 
including an N-terminal StrepII-sequence (WSHPQFEK) instead of 
the pelB-sequence. The StrepII-adaptor was inserted between the 
restriction sites NheI und BamH I. 
pEndoNF :  Eukaryotic expression vector based on pET22b-Strep for expression 
of N-terminally  StrepII- tagged and C-terminally His6-tagged 
endoNF. EndoNF was inserted using the restriction sites BamHI 
and XhoI. 
p∆245-EndoNF : Eukaryotic expression vector based on pET22b-Strep for expression 
of N-terminally by 245 amino acids truncated endoNF with N-
terminal StrepII- tag and C-terminal His6-tag. The truncated 
endoNF was inserted using the restriction sites BamHI and XhoI. 
p∆245-EndoNF-E525A : Eukaryotic expression vector similar to p∆245-EndoNF for 
expression of mutant endoNF. The glutamic acid in position 525 
was mutated to alanine by site directed mutagenesis using the 
primer pair  KS61/KS62. 
p∆245-EndoNF-E581A : Eukaryotic expression vector similar to p∆245-EndoNF for 
expression of mutant endoNF. The glutamic acid in position 581 
was mutated to alanine by site directed mutagenesis using the 
primer pair  KS63/KS64. 
p∆245-EndoNF-R596A : Eukaryotic expression vector similar to p∆245-EndoNF for 
expression of mutant endoNF. The arginine in position 581 was 
mutated to alanine by site directed mutagenesis using the primer 
pair  KS65/KS66. 
p∆245-EndoNF-R647A : Eukaryotic expression vector similar to p∆245-EndoNF for 
expression of mutant endoNF. The arginine in position 647 was 
mutated to alanine by site directed mutagenesis using the primer 
pair  KS67/KS68. 
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4.1.4 Oligonucleotides 
Sequencing primers (5’ ➠ 3’) Target sequence  
KS2f TGTAATCAGGTGCAAT ST8SiaIV  
KS7f TATCCGGATTATTCA pFastBac  
T7 TAATACGACTCACTATA pET22b  
T7term GCTAGTTATTTGCTCAGCGG pET22b  
MM104 GTCAGAGCCGTGCATCAA endoNF  
 
PCR amplification primers (5’ ➠ 3’) 
 
Target sequence 
 
KS1f GACTCGAGAGCCAGAACTGAGGAGCAC ST8SiaIV XhoI 
KS1r CTAAGCTTTCAATGATGATGATGATGATG pMyc-ST8SiaIV HindIII 
MM35 ATGCCATGGCCAGAACTGAGGAGCAC ST8SiaIV NcoI 
Ks9r TGAAGCTTTTATTGCATTCATGCACTTCCCTGT ST8SiaIV HindIII 
KS15 GAGAGCTCGCATCACCATCACCATCACGAT pFastBac-HT SacI 
 
Mutagenesis primers (5’ ➠ 3’) 
 
Target sequence 
 
KS61 TCCCTAGTGTCACAGCTGTGCATAGCTTT endoNF E525A 
KS62 GCAAAGCTATGCACAGCTGTGACACTAGGGA - endoNF E525A 
KS63 CCAGATGCGTCAGCGCCGTGCATCAAG endoNF E581A 
KS64 CTTGATGCACGGCGCTGACGCATCTGG endoNF E581A 
KS65 GGTGTATTATACCTTATCACTGCAGGCACTCGTGGTGATAGACT endoNF R596A 
KS66 AGTCTATCACCACGAGTGCCTGCAGTGATAAGGTATAATACACC endoNF R596A 
KS67 CCTTATTATGTTTGGTTCAGAAGCTGCAGAAAATGAATGGGAAGC endoNF R647A 
KS68 GCTTCCCATTCATTTTCTGCAGCTTCTGAACCAAACATAATAAGG endoNF R647A 
 
4.1.5 Chromatography columns and media 
Superdex 200 HR 10/30 Amersham Biosciences 
HiPrep 26/10 Desalting Amersham Biosciences 
StrepTactin affinity matrix IBA 
ProBond Ni2+ affinity matrix Invitrogen 
HiTrap Chelating (5ml) Amersham Biosciences 
Protein G-sepharose Amersham Biosciences 
IgG-Sepharose Amersham Biosciences 
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4.1.6 Antibodies 
anti-T7 mAb : monoclonal antibody (mouse IgG 2b) directed against the T7-
epitope (MTGGQQM) (Novagen) 
anti-penta His mAb : monoclonal antibody (mouse IgG) directed against the His6-epitope 
(HHHHHH) (Qiagen) 
anti-myc mAb (9E10) : monoclonal antibody (mouse IgG 1) directed against the myc-
epitope (EQKLISEELDL) (Roche) 
735 mAb : monoclonal antibody (mouse IgG 2a) directed against poly-α2,8-N-
acetylneuraminic acid with a minimum chain length of eight 
residues (Frosch et al., 1985) 
735-bio-fab : Fab’2 fragments of mAb 735 conjugated with biotin 
anti-mouse-AP :  polyclonal goat anti mouse IgG conjugated with alkaline 
phosphatase (Dianova) 
anti-mouse-POX  : polyclonal goat anti mouse IgG conjugated with horseradish 
peroxidase (Southern) 
mouse IgG : mouse IgG (Pierce) 
streptavidine-POX  : streptavidine horseradish peroxidase conjugate (Roche) 
 
4.1.7 Molecular weight markers 
‘1 kb DNA ladder’ (Invitrogen) 
 [kb]: 0.08; 0.13; 0.15; 0.20; 0.2; 0.30; 0.34; 0.40; 0.51; 0.52; 1.0; 1.6; 2.1; 3.1; 4.1; 
5.0; 6.1; 7.1; 8.1; 9.2; 10.2; 11.2; 12.2 
 
‘λ-DNA / HindIII-Fragments’ (Invitrogen) 
 [kb]: 0.14; 0.56; 2.03; 2.23; 4.63; 6.68; 9.41; 23.13 
 
‘SDS-PAGE molecular weight standards high range’ (BioRad) 
 [kDa]: 45; 66; 97; 116; 200 
 
‘SDS-PAGE molecular weight standards low rage’ (BioRad) 
 [kDa]: 14; 22; 31; 45; 66; 97 
 
‘Unstained Precision Protein Standards’ (BioRad) 
 [kDa]: 10; 15; 20; 25; 37; 50; 75; 100; 150; 250 
 
‘[14C]-Methylated Proteins’ [5 µCi/ml]’ (Amersham Biosciences) 
 [kDa]: 14,3; 30; 46; 66; 97,4; 100; 220 
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4.1.8 Chemicals 
ABTS  Roche 
Acetic acid (100 %) Merck 
Aceton Baker 
Acrylamide 40% 4 K-Mix (37,5:1) Serva 
Agarose Serva 
Ammonium chloride  Merck 
Ammonium persulphate (APS) Serva 
Ampicillin, sodium salt Serva 
Aprotinin   Bayer 
Avidin Sigma 
BCA Protein Assay Reagent  Pierce  
BCIP (5-Brom-4-chlor-3-indolyl-phosphat) Fluka 
Bestatin Sigma 
Beta-Mercaptoethanol Sigma 
Bluo-gal Invitrogen 
Borate, solium salt Merck 
Bromphenol Blue, sodium salt Applichem 
BSA (Fraktion V) Applichem 
BSA protein standard Pierce 
Carbenicillin, disodium salt Fluka 
CELLfectin transfection reagent Invitrogen 
Chloroform Baker 
Citric acid Merck 
Colominic acid Sigma 
Cytidine 5’-monophosphat [14C]sialic acid Amersham Biosciences
Cytidine 5’-monophosphat sialic acid Sigma 
Desthiobiotin Sigma 
Dimethylformamide (DMF) Fluka 
Dimethylpimelimidate Sigma 
Dimethylsulfoxide (DMSO) Merck 
Dipotassium hydrogenphosphate Merck 
Disodium hydrogenphosphate  Merck 
Disodium hydrogenphosphate Merck 
Dithiothreitol (DTT) Sigma 
dNTPs (100 mM each) Pharmacia 
Dry milk Applichem 
EDTA, Disodium salt (Titriplex III) Merck 
Ethanol, abs. Baker 
Ethidium Bromide USB Corporation 
Formaldehyde Sigma 
Gentamicin Sigma 
D-glucose Sigma 
Glycerine (99%) KMF 
Glycine Sigma 
Hydrochloric acid (38%) Baker 
Imidazole Fluka 
IPTG (Isopropyl-beta-D-thiogalactopyranoside)  Merck 
Isopropanol (2-Propanol) Merck 
Kanamycin Sigma 
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Korsolex plus Roche 
LipofectAMINE transfection reagent Invitrogen 
Lithium sulphate Sigma 
Magnesium chloride hexahydrate Merck 
Magnesium sulphate Baker 
Manganese chloride Merck 
MES (2-(N-Morpholino)ethanesulphonic acid) Merck 
Methanol Baker 
L-methionine Sigma 
NBT (Nitrotetrazolium bluechloride) Fluka 
Pepstatin Roche 
Phenylmethylsulfonyl fluorid (PMSF) Sigma 
Polyethyleneglycol, various from PEG300 to PEG 20000 Sigma 
Ponceau S, sodium salt Sigma 
Potassium dihydrogenphosphate Merck 
Roti-Blue Coomassie-stain (5x) Roth 
D/L-selenomethionine Sigma 
Sialic acid (5-N-acetylneuraminic acid) Serva 
Sialic acid pentamer α2,8-linked Calbiochem 
Sodium acetate Merck 
Sodium azide  Merck 
Sodium cacodylate (‘Dimethylarsinic acid’) Sigma 
Sodium chloride Merck 
Sodium dihydrogenphosphate  Merck 
Sodium dodecylsulphate (SDS) Merck 
Sodium hydroxide Merck 
Sodium meta-arsenite  Merck 
Sodium periodate  Sigma 
Streptavidine Horseradish peroxidase conjugate Roche 
TEMED (N,N,N’,N’-Tetramethyl-ethylendiamin) Serva 
Tetracycline Sigma 
Tetramethyl benzidine (TMB) Sigma 
Thiamin Sigma 
Thiobarbituric acid  (TBA) Sigma 
Tricine (N-Tris(hydroxymethyl)-methylglycine) Serva 
TRIS (Tris(hydroxymethyl)-aminomethan) Merck 
 
All chemicals not explicitly listed above were purchased in p.a. quality from either Merck or  
Sigma. 
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4.1.9 Culture media and additives 
DMEM/Hams F12 Biochrom 
OptiMEM Invitrogen 
Fetal calf serum Invitrogen 
Sf-900 II SFM Invitrogen 
L-Glutamine Biochrom 
LB-medium  Becton Dickinson 
LB-agar Becton Dickinson 
 
4.1.10 Standardbuffer and media 
2xGEBS 20% glycerol,  
50 mM EDTA 
0,05% bromephenol Blue,  
0,5% sarcosyl 
2xLaemmli 200 mM Tris-HCl pH 6,8, 
30% (v/v) gycerol, 
3% (w/v) SDS,  
0,1% (w/v) bromephenol Blue 
BCIP 25 mg/ml BCIP in 100% DMF 
M9- medium 42 mM Na2HPO4, pH 7.4 
22 mM KH2PO4 
0.05% (w/w) NaCl 
19 mM NH4Cl 
2 mM MgSO4 
0.4% (w/w) glucose 
0.1 mM CaCl2 
2 mg/l thiamin, 2 mg/l biotin 
NBT 50 mg/ml NBT in 70% (v/v) DMF 
PBS 10 mM sodium phosphate pH 7,4 
150 mM NaCl 
PBS/EDTA 10 mM sodium phosphate, pH 7,4 
150 mM NaCl 
2 mM EDTA 
TBE 100 mM Tris-HCl, pH 8,0 
100 mM Borate 
2,5 mM EDTA 
TE  10 mM Tris-HCl, pH 8,0 
1 mM EDTA 
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4.1.11 Enzymes 
Alkaline calf intestine phosphatase New England Biolabs  
T4-DNA-Ligase  New England Biolabs  
cloned Pfu-DNA-Polymerase  Stratagene 
Taq-DNA-Polymerase  Sigma 
Lysozyme Serva 
Restriction enzymes:  BamHI, DpnI, HindIII, NheI, NcoI,   
 SacI, XhoI,  
New England Biolabs 
 
4.1.12 Laboratory equipment 
Blotting chamber  Fast-Blot B44 Biometra 
Easy Enhanced Analysis System  
(E.A.S.Y RH-3, Videokamera 429K) 
Herolab 
Elektrophoresis chamber for agarose-gels peqlab 
Elektrophoresis chamber for SDS-PAGE BioMetra 
ELISA-Reader: DigiScan Asys Hitech 
FPLC-system ÄKTA  Amersham Biosciences 
Heatingblock TB1 BioMetra 
HeraSafe Hood Heraeus 
Incubators Heraeus 
Peristaltikpump P-1 Amersham Biosciences 
Scales CP 224S (µg) / CP 3202 (g) Sartorius 
Sonifier 450 Branson 
Spectrophotometer Ultrospec 2100 pro Amersham Biosciences 
Speedvac RVC 2-18 Christ 
Standard Power Pack P25 Biometra 
Thermocycler T1 und T Gradient Biometra 
Thermomixer compact Eppendorf 
Centrifuges :  - Biofuge fresco  
 - Biofuge pico  
 - Multifuge 3 S-R 
 - Centrifuge 5415C 
 - Coulter Avanti J-30I 
 - Centrikon T-1170 
Rotors: - JA 25.50 
 - JLA 10.500 
 - JS-24.15 
Heraeus  
Heraeus 
Heraeus 
Eppendorf 
Beckman 
Kontron 
Beckman 
Beckman 
Beckman 
X-ray generators:   - MicroMax-007 
  - RU-H3R 
Detektor: - mar345 DTB 
Rigaku msc 
 
MARresearch 
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4.1.13 Consumables and Kits 
Cell culture bottles and dishes Sarstedt 
Concert High Purity Plasmid MiniPrep System Invitrogen 
Cryschem plates, polystyrene (24 wells) Hampton Research 
Crystal Clear sealing tape Hampton Research 
Culture dishes (92 x 16 mm, PS) Sarstedt 
Filterpaper 3MM Whatman 
Hyperfilm MP Amersham Biosciences 
Microtiterplates 96-well polystyrol (U-bottom) Greiner 
Microtiterplates MicroTest III Flexible Assay Plate Becton Dickinson 
Nitrocellulose membrane (0,45 µm) Schleicher & Schuell 
PCR-tubes (0,2 ml) Biozym 
Plastic disposable pipettes (5 ml, 10 ml, 25 ml) Sarstedt 
Polypropylentubes (14 ml, 50 ml) Greiner 
QIAGEN Plasmid Mini und Midi Kit QIAGEN 
QIAquick Gel Extraction Kit QIAGEN 
Reaction tubes (0.5 ml, 1.5 ml) Sarstedt 
Reaction tubes safelock (1.5 ml, 2 ml) Eppendorf 
Sterile filters Millex GP (0,22 µM) Milipore 
Syringes (1 ml, 5 ml, 10 ml) Braun 
VivaFlow50 crossflow filtration units  
(PES membrane, 10 kDa MWCO 
Vivascience 
Vivaspin concentrator 20 ml  Vivascience 
 
4.2 Molecular biological techniques 
4.2.1 Analytical plasmid preparation 
3 ml LB medium containing the appropriate antibiotic were inoculated with a single bacterial 
colony from a selective agar plate and incubated for 12-16 h at 37°C and 250 rpm. 1.5 ml of 
the culture were pelleted by centrifugation (20 sec, 14500xg, RT) and resuspended in 100 µl 
buffer P1 (50 mM Tris/HCl pH 8.0, 10 mM EDTA, 100 µg/ml RnaseA). 100 µl of buffer P2 
(1 % SDS, 0.2 M NaOH) and 100 µl of chilled buffer P3 (3,0 M potassium acetate, pH 5.5) 
were added, each buffer addition followed by a cautions mixing step. The samples were 
centrifuged (5 min, 14500xg, RT) and 300 µl of isopropanol were added to the supernatant 
followed by 5 min incubation at room temperature. The plasmid DNA was then pelleted by 
centrifugation (10 min, 14500xg, RT), washed in 500 µl ethanol (70 %) and again centrifuged 
(5 min, 14500xg, RT). The dried pellet was dissolved in 20 µl TE buffer. 
 
MATERIALS AND METHODS 25
4.2.2 Preparative plasmid preparation 
For plasmid isolation in preparative scale the ‘Qiagen plasmid Kit Midi’ was used according 
to the manufacturers instructions. 
A starter culture was generated by incubating 3 ml LB medium (200 µg/ml carbenicillin) 
inoculated with single bacterial colony from a selective agar plate for 12-16 h at 37°C and 250 
rpm. 200 µl of the starter culture were diluted in 100 ml LB medium (200 µg/ml carbenicillin) 
and again incubated for 12-16 h at 37°C and 250 rpm. The culture was centrifuged (15 min, 
6000xg, 4°C) and the bacterial pellet resuspended in 4 ml buffer P1 (50 mM Tris/HCl pH 8.0, 
10 mM EDTA, 100 µg/ml RnaseA). After the addition of 4 ml buffer P2 (1 % SDS, 0.2 M 
NaOH) and cautious mixing the bacterial lysis was allowed to proceed for 5 min at room 
temperature. Then 4 ml of chilled buffer P3 (3,0 M potassium acetate, pH 5.5) were added, 
the sample was again cautiously mixed, incubated on ice for 15 min and centrifuged (30 min, 
20000xg, 4°C). The supernatant instantly was applied to a QIAGEN-Tip 100 column 
equilibrated in buffer QBT (750 mM NaCl, 50 mM MOPS pH 7.0, 15% isopropanol, 0.15% 
(v/v) TritonX-100). After two washing steps with 10 ml buffer QC (1 M NaCl, 50 mM MOPS 
pH 7.0, 15% isopropanol) the bound plasmid DNA was eluted in 5 ml buffer QF (1.25 M 
NaCl, 50 mM Tris-HCl pH 8,5, 15% isopropanol) and 3.5 ml isopropanol were added to the 
eluent. After centrifugation (30 min, 20000xg, 4°C) the pelleted DNA was washed in 2 ml 
ethanol (70 %) and recentrifuged (15 min, 20000xg, 4°C). The dried DNA pellet was 
dissolved in 200 µl TE buffer and stored at -20°C. The DNA concentration was determined as 
described in 4.2.4. 
 
4.2.3 Agarose gel electrophoresis of DNA 
DNA samples were diluted in 2xGEBS and separated on horizontal agarose gels (0.6 to 1.5 % 
agarose in TBE buffer). Electrophoresis was performed at 5 V/cm in TBE buffer. The DNA 
was detected after staining in ethidium bromide (50 µg/ml) at 302 nm. For documentation the 
‘Easy Enhanced Analysis System’ (Herolab) was used.  
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4.2.4 Determination of DNA concentrations 
DNA concentrations were determined photometrically and calculated from the absorbance 
measured at 260 nm: c(DNA) = absorbance(260 nm) x 50 µg/ml. Very low DNA 
concentrations were estimated by comparing the signal intensity obtained on ethidium 
bromide stained agarose gels with known concentrations of  λ-HindIII-marker.  
 
4.2.5 Restriction digest of DNA 
Restriction enzymes and reaction buffers were used according to the manufacturers 
instructions. For preparative digests 2-5 µg of DNA were incubated with 5-20 U of enzyme 
for 60-120 min at 37°C while the added volume of enzyme solution never exceeded 10 % of 
the total sample volume. For analytical digests 5 µl of plasmid DNA (4.2.1) were incubated 
for 30 min at 37°C with 2-5 U of enzyme.  
 
4.2.6 Dephosphorylation of DNA 
The 5´-phosphate groups of linearised vector DNA were removed to avoid self-ligation of the 
vector fragments. Per µg of vector DNA 1 U of calf intestine alcaline phosphatase (NEB) was 
directly added to the restriction mix.   
 
4.2.7 Isolation of DNA fragments form agarose gels 
To isolate DNA fragments after restriction digest, DNA was separated on an agarose gel 
(4.2.3) and the desired fragments were excised from the gel. For further DNA purification the  
‘Qiaquick PCR Purification Kit’ (Qiagen) was used according to the manufacturers 
instructions. The gel slice was completely dissolved in 300 µl buffer QG per 100 mg gel at 
50°C and applied to a Qiaquick column. After one washing step with 500 µl buffer PE bound 
DNA was eluted in 30 µl EBC (10 mM Tris-Cl pH 8,5). Sample and buffer applications were 
mediated by centrifugation (60 sec, 14500xg, RT) of the column.  
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4.2.8 Ligation of DNA 
20 fmol of digested and dephosphorylated vector DNA and 100 fmol of the respective insert 
were incubated with 1 Weiss-U of T4-DNA-Ligase (NEB) in 20 µl ligation buffer (50 mM 
Tris-HCl pH 7.8, 10 mM MgCl2, 1 mM ATP, 10 mM DTT, 25 µg/ml BSA). The ligation mix 
was either incubated for 2 h at RT or overnight at 16°C and transformed into competent 
E. coli cells.  
 
4.2.9 Preparation of CaCl2-competent E. coli  
100 ml SOB medium were inoculated with 5 ml of an overnight starter culture and grown at 
37°C and 250 rpm to an optical density of OD600 = 0.5. The culture was incubated on ice for 
10 min and centrifuged (10 min, 4000xg, 4°C). The bacterial pellet was carefully resuspended 
in 30 ml of ice-cold TB (10 mM MES pH 6.7, 15 mM CaCl2, 250 mM KCl, 55 mM MnCl2), 
incubated for 10 min on ice and centrifuged (10 min, 4000xg, 4°C). The pellet was again 
carefully resuspended in 8.6 ml TB including 0.6 ml DMSO and aliquots of 200 µl were flash 
frozen in liquid nitrogen and stored at -80°C. This protocol was used to prepare competent 
E. coli of the strains DH5α, JM109, XL1Blue, BL21(DE3) and BL834(DE3). To prepare 
competent E. coli DH10Bac, 50 µg/ml kanamycin and 10 µg/ml tetracycline were added to 
the SOB-medium. 
 
4.2.10 Transformation of competent E. coli  
50-200 µl of competent E. coli were thawed on ice and 10 ng of plasmid DNA or 10 µl of 
ligation mix (4.2.8) were added. The mix was left on ice for 15 min, subjected to a 45 sec heat 
shock at 42°C and incubated on ice for another 15 min. 500 µl of LB-medium was added, the 
cell suspension was incubated at 37°C for 30 min and plated on selective LB-agar plates 
containing the appropriate antibiotics. 
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4.2.11 Polymerase chain reaction (PCR) 
To amplify DNA-fragments by PCR reaction, 10-50 ng of plasmid DNA, sense and antisense 
primer (100 pmol each), 5 U Pfu-polymerase (Stratagene) and dNTP´s (20 µM each) were 
mixed in a total volume of 100 µl 1xPCR buffer (Stratagene). The PCR-mix was incubated in 
a Thermocycler for 25-30 of the following cycles: 45 sec at 94°C to denature double stranded 
DNA, 60 sec to anneal the oligonucleotide primers (5°C below their calculated melting point) 
and elongation at 72°C for 120 sec per kb of synthesis product. In the last cycle the elongation 
step was extended to 10 min. PCR reaction were either performed using the ‘GeneAmp 
System 2400’ (Perkin Elmer) or the ‘T1-Thermocycler’ (Biometra). 
 
4.2.12 Site-directed mutagenesis 
To generate mutant recombinant proteins by site-directed mutagenesis a protocol derived 
from the ‘QuikChangeTMSite-Directed Mutagenesis Kit’ (Stratagene) was used. Mutations are 
site-specifically introduced by a mutant sense/antisense primer pair that is used to amplify the 
complete plasmid in a PCR-reaction. Methylated template DNA is then digested by DpnI and 
the mutated synthesis product is transformed in competent E. coli cells.  
50 ng of template DNA, mutant sense and antisense primer (10 pM each), 5 U Pfu-
polymerase (Stratagene) and dNTP´s (20 µM each) were mixed in a total volume of 50 µl 
1xPCR buffer (Stratagene). The PCR-reaction was performed as described in 4.2.11 for a total 
of 16 cycles. 10 U of DpnI were added and the sample was incubated for 1 h at 37°C. 2 µl of 
the sample were transformed in competent E. coli cells as described in 4.2.10. Introduction of 
the correct mutations was confirmed by DNA sequencing.  
 
4.3 Cell biological techniques 
4.3.1 Cultivation of CHO cells 
Chinese hamster ovary (CHO) cells were kept in a humidified incubator at 37°C and 5 % 
CO2. Cells were cultured in DMEM/HAM´s F12 medium (Biochrom) supplemented with 
1 mM sodium pyruvate and 5 % fetal calf serum (FCS). Confluent cell layers were treated 
with PBS/EDTA to detach the cells from the culture vessel and diluted 1:10 in fresh medium. 
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For long term storage in liquid nitrogen, cells were pelleted by centrifugation (5 min, 200xg, 
RT) and resuspended in culture medium containing 20 % FCS and 10 % DMSO at a 
concentration of 1x107 cells/ml. Aliquots of 1 ml were filled in cyro vials, stored overnight at 
-80°C and then transferred to liquid nitrogen.  
To recover frozen cell pellets, they were kept on dry ice for 5-10 min, thawed in a water bath 
at 37°C and diluted by drop wise addition of culture medium containing 10 % FCS. After 
centrifugation (5 min, 200xg, RT) the cell pellet was again resuspended in culture medium 
(10 % FCS) and transferred to culture vessels. 
 
4.3.2 Transfection of CHO cells 
For transient transfection of CHO cells 2x106 cells were seeded in 90-mm culture vessels and 
cultivated over night as described in 4.3.1. A transfection mix was prepared by diluting 4 µg 
of plasmid DNA and 24 µl of Lipofectamine in 400 µl OptiMEM (Invitrogen) each. Both 
dilutions were combined and incubated for 15-30 min at RT. 
The CHO cell layer (70-80 % confluent) was washed twice in PBS and incubated with freshly 
prepared transfection mix diluted with 3.2 ml OptiMEM for 6 h. The transfection was stopped 
by the addition of 4 ml DMEM/HAM´s F12 medium (Biochrom) supplemented with 1 mM 
sodium pyruvate and 10 % fetal calf serum (FCS). The medium was replaced 24 h after begin 
of the transfection with 8 ml culture medium containing 5 % FCS and cells were cultivated 
for another 48 h. 
 
4.3.3 Cultivation of Sf9 cells 
Suspension cultures of Spodoptera frugiperda (Sf9) cells were cultivated at 27°C and 100 rpm 
in Sf900-II SFM medium (Invitrogen). Cell density was maintained between 0.5x106 and 
8x106 cells per millilitre by diluting dense cultures in fresh medium.  
For long term storage in liquid nitrogen, cells were pelleted by centrifugation (5 min, 200xg, 
RT) and resuspended in the conditioned culture medium containing 10 % DMSO at a 
concentration of 1x107 cells/ml. Aliquots of 1 ml were filled in cyro vials and cooled down by 
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subsequent incubations at 4°C and -20°C for 1 h each. Cells were stored overnight at -80°C 
and then transferred to liquid nitrogen.  
To recover frozen cell pellets, they were kept on dry ice for 5-10 min, thawed in a water bath 
at 37°C and directly added to 30 ml culture medium in a culture vessel.  
 
4.3.4 Generation of recombinant baculoviruses 
Recombinant baculoviruses were generated on basis of transposon-mediated recombination 
(Luckow et al., 1993) in E. coli DH10Bac cells (Invitrogen) using pFastBac baculovirus 
transfer vectors.  
4.3.4.1 Preparation of recombinant bacmid DNA 
100 µl of competent E. coli DH10Bac were thawed on ice and incubated for 30 min with 
20 ng of the respective pFastBac vector construct. The transformation mix was subjected to a 
heat shock at 42°C for 45 sec and incubated on ice for another 2 min. 900 µl of SOC-medium 
were added, the cell suspension was incubated at 37°C for 4 h and plated on selective LB-agar 
plates containing 50 µg/ml kanamycin, 7 µg/ml gentamicin, 10 µg/ml tetracycline and 
40 µg/ml IPTG. For blue-white screening additionally 30 µl of BluoGal solution (20 mg/ml in 
DMSO) was spread on the plates prior to plating. Positive transformants were identified after 
48 h incubation at 37°C as purely white colonies and restreaked on fresh plates to confirm the 
white phenotype. 5 ml LB-medium containing 50 µg/ml kanamycin, 7 µg/ml gentamicin and 
10 µg/ml tetracycline was inoculated with a positive colony and incubated overnight at 37°C 
and 250 rpm. Bacmid DNA was isolated using the ‘Concert High Purity Pasmid Kit’ 
(Invitrogen) according to the manufacturers instructions. Briefly, 3 ml of bacterial culture 
were pelleted (1 min, 14500xg, RT), resuspended in 0.4 ml buffer ‘E1’ and lysed for 5 min at 
RT after addition of 0.4 ml buffer ‘E2’. 0.4 ml neutralisation buffer ‘E3’ was added, the 
samples were centrifuged (10 min, 14500xg, RT) and the supernatant was applied to ‘Concert 
HP’ columns equilibrated in buffer ‘E4’. After two washings steps with 2.5 ml buffer E5 
bound bacmid DNA was eluted in 0.9 ml buffer ‘E6’. 0.63 ml isopropanol were added to the 
eluent and the pelleted DNA (30 min, 14500xg, 4°C) was washed in 1 ml ethanol (70 %) and 
recentrifuged (15 min, 20000xg, 4°C). The bacmid DNA pellet was airdried for 10 min, 
dissolved in 50 µl TE and used for transient transfections of Sf9 cells (4.3.4.2). 
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4.3.4.2 Production of recombinant baculoviruses and high-titer virus stocks 
Baculoviruses were produced by transfecting the prepared recombinant bacmid DNA 
(4.3.4.1) into Sf9 cells. 1x106 log-phase Sf9 cells were seeded in 2 ml culture medium per well 
of a 6-well tissue culture plate. The cells were allowed to attach to the culture plate for 1 h at 
27°C. In the meantime a transfection mix was prepared by diluting 5 µl of the bacmid DNA 
prep and 6 µl of Cellfectin in 100 µl Sf900-II medium (Invitrogen) each. Both dilutions were 
combined and incubated for 30 min at RT. 
The medium was aspirated from the adhered Sf9 cells and replaced with transfection mix 
diluted in 1 ml Sf900-II medium. The transfection mix was removed after 12 h and replaced 
with 2 ml culture medium. The transfected cells were incubated at 27°C for 4-8 days until 
signs of viral infection like enlarged cell diameters and a granular appearance of the cells 
were clearly visible.  
The supernatant (low-titer P1-stock) was harvested and stored at -80°C. For virus 
amplification 2x106 Sf9 cells were seeded in 4 ml in a 25 cm2 cell culture bottle and infected 
with 40 µl of the P1-stock. The P2-stock was harvested after 4 days, sterile filtered and stored 
at -80°C. Large P3-stocks were obtained by infecting 50 ml suspension cultures (2x106 
cells/ml) with 100 µl of the P2-stock. The virus stock was harvested after 48 h. Cells were 
pelleted by centrifugation (5 min, 500xg, RT), the supernatant was sterile filtered and stored 
at 4°C.  
 
4.3.5 Baculoviral expression of ST8SiaIV∆25 in Sf9 cells 
For baculoviral expression of recombinant ST8SiaIV∆25 log-phase Sf9 cells at a density of 
2x106 cells/ml were infected with the respective high titer virus stock and grown for 72 h at 
27°C and 150 rpm before the culture supernatant was harvested (700xg, 10 min, 4°C). The 
dose of baculovirus required for optimal expression was tested for each lot of high titer stocks 
in small scale test expressions. 30 ml suspension cultures of Sf9 cells at a density of 2x106 
cells/ml were infected with different amounts of the viral stock (from 30 µl to 300 µl). Culture 
supernatants were assayed for protein expression by SDS-PAGE (4.4.2) and Western blot 
analysis (4.4.5) 72 h after infection and the optimal of dose viral stock per millilitre of 
expression culture was used for further large scale expressions.  
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4.4 Biochemical techniques 
4.4.1 Protein estimation 
Protein concentrations were estimated using the ‘BCA Protein Assay Reagent’ (Pierce) 
according to the manufacturers instructions. Briefly, reagents A and B were mixed 50:1 
immediately before use. 200 µl of the mixture were added to 10 µl sample and incubated at 
55°C for 30 min in 96-well microtiter plates. As reference, samples with known BSA 
concentrations were included. The absorbance of all samples was measured at 540 nm using 
the ELISA-Reader ‘DigiScan’ (Asys Hitech) and protein concentrations were calculated from 
the BSA standard curve. 
4.4.2 Polyacrylamide gelelectrophoresis (SDS-PAGE) 
SDS-PAGE was performed according to Laemmli (Laemmli, 1970). Protein samples were 
seperated on SDS-polyacrylamide gels composed of a 3 % stacking gel (125 mM Tris/HCl 
pH 6.8, 0.1 % SDS, 3 % polyacrylamide) and a 7-14 % separating gel (375 mM Tris/HCl 
pH 8.8, 0.1 % SDS, 7-14 % polyacrylamide). Gels were prepared by mixing buffer, SDS and 
the acrylamide stock solution (37,5 % acrylamide, 1 % bisacrylamide) and polymerisation 
was initiated by adding 0,1 % TEMED and 1 % ammonium persulphate. Samples were mixed   
with 2xLaemmli-buffer and either heated to 95 °C for 5 min or to 60 °C for 20 min if they 
contained heat-labile polysialic acid.  Electrophoresis was performed in SDS-electrophoresis 
buffer (50 mM Tris, 350 mM glycine, 0.1 % SDS) at 70 V (stacking gel) and 140 V 
(separating gel), respectively.   
 
4.4.3 Coomassie staining of polyacrylamide gels 
For Coomassie staining of protein gels, the colloidal staining solution Roti®-Blue (Roth) was 
used.  The gels were directly after electrophoresis (4.4.2) incubated overnight in 50 ml 
1xRoti®-Blue in 20 % methanol, destained for 1 h in 25 % methanol and dried after 1 h 
incubation in drying-buffer (20 % ethanol, 10 % glycerol).  
 
MATERIALS AND METHODS 33
4.4.4 Silver staining of polyacrylamide gels 
For silver staining the gels were directly after electrophoresis incubated for 1 h or overnight in 
fixing solution (30 % ethanol, 10 % acetic acid, 1.85 % formaldehyde). After two washing 
steps (20 min, 50 % ethanol) the gels were incubated for exactly 1 min in thiosulphate 
solution (20 mg/100 ml), washed three times for 20 sec in deionised water and incubated for 
20 min in staining solution (0.2 % (w/w) AgNO3, 2.8 % formaldehyde). After two washing 
steps in deionised water for 20 sec, the gels were incubated in freshly prepared developer 
solution (6 % (w/w) NaCO3, 2 % (v/v) thiosulphate solution, 1.85 % formaldehyde) until 
protein bands were lighting up. The reaction was stopped by transferring the gels to stop 
solution (30 % ethanol, 10 % acetic acid) and gels were dried after 1 h incubation in drying-
buffer (20 % ethanol, 10 % glycerol).  
 
4.4.5 Western Blotting 
By SDS-PAGE separated proteins were transferred to nitrocellulose membranes using a 
semidry blotting chamber (Biometra) at 2 mA/cm2 for 1 h.  Gel and membrane were placed 
between two layers of Whatman filter paper soaked in blotting buffer (48 mM Tris, 39 mM 
glycine). To check the transfer efficiency and to label the bands of the molecular weight 
standard, the membrane was reversibly stained in Ponceau S-solution (0.2 % (w/v) Ponceau S 
in 3 % TCA) and destained in deionised water and PBS.  
 
4.4.6 Immunostaining of Western Blots 
The nitrocellulose membranes were incubated for 1 h at RT or at 4°C overnight in blocking 
solution (2 % drymilk in PBS, 0.02 % NaN3). After two washing steps for 5 min in PBS the 
membranes were incubated for 1 h with the primary antibodies in blocking solution 
(9E10: 5 g/ml, anti-T7 (Novagen): 1 µg/ml), washed again twice for 5 min in PBS and were 
finally incubated for 30 min with alkaline phosphatase-conjugated secondary antibody 
(1:2000, Dianova) in blocking solution. For colour development membranes were rinsed 
twice in PBS, once in AP-buffer (100 mM Tris-HCl pH 9.5, 100 mM NaCl, 5 mM MgCl2) 
and stained with BCIP/NBT solution (0.3 mg/ml NBT, 0.15 mg/ml BCIP in AP-buffer). 
MATERIALS AND METHODS 34
4.4.7 Covalent coupling of mAb 9E10 to protein G-sepharose 
For covalent coupling 20 mg of purified mAb 9E10 (4.4.10) were incubated for one hour at 
RT with 5 ml protein G-sepharose matrix. The bead were washed twice in 50 ml sodium 
borate (0.2 M, pH 9.0) by centrifugation (5 min, 10.000xg, 4 °C), resuspended in 50 ml 
sodium borate (0.2 M, pH 9.0) and the coupling reaction was started by addition of 
5.184 mg/ml dimethylpimelimidate (solid). The reaction was stopped after 30 min by washing 
the beads once in 50 ml ethanolamine (0.2 M, pH 8.0) by centrifugation  (5 min, 10.000xg, 
4 °C). The beads were resuspended in 50 ml ethanolamine (0.2 M, pH 8.0), incubated at RT 
for 2 h and after a final washing step resuspended in 10 ml PBS (0.02 % NaN3). The 
efficiency of the coupling reaction was checked by Coomassie stained SDS-PAGE.  
 
4.4.8 Expression of recombinant proteins in E. coli 
For bacterial expression of recombinant proteins the pET-vector system (Novagen) was used. 
30 – 1000 ml cultures of E. coli BL21(DE3) transformed with the respective expression 
plasmids (4.2.10) were grown in LB medium (200 µg/ml carbenicillin) at 37 °C and 250 rpm 
to an optical density of OD600 = 0.6. The cultures were induced with 1 mM IPTG and 
harvested after 2 h by centrifugation (15 min, 6000xg, 4 °C). The bacterial pellet was stored at 
–20 °C.  
 
4.4.9 Preparation of soluble and insoluble E. coli fractions 
For analytical preparations bacterial pellets obtained from 1 ml of expression culture (….) 
were resuspended in 100 µl TE buffer, 10 µg of lysozyme was added and the samples were 
incubated at 37 °C for 15 min.  After sonification in a beaker resonator (Branson, 50 % duty 
cycle, level 5) for 2 min at 4 °C the soluble (supernatant) and insoluble fractions (pellet) were 
separated by centrifugation (15 min, 14500xg, 4 °C).  
For large scale preparative set-ups the bacterial pellets obtained from 0.5 l expression culture 
were resuspended in 5 ml buffer A (10 mM Tris/HCl pH 8.0, 300 mM NaCl) and the protease 
inhibitors bestatin (40 µg/ml), PMSF (1 mM) and pepstatin (4 µg/ml) were added. The 
bacteria were lysed by sonification (Branson sonifier, 100% duty cycle, level 5) for 30 sec on 
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ice. The procedure was repeated 6 times with a break of 30 sec between the repeats. After 
centrifugation (15 min, 14500xg, 4 °C) the supernatant was filtered (Millex-GP, 0.22 µm) and 
applied to subsequent purification steps (4.4.13) 
 
4.4.10 Purification of mAb 9E10 
The monoclonal antibody 9E10 was purified from the culture supernatant of hybridoma cells 
by protein G-affinity chromatography. 500 ml of cell culture supernatant stored at –20 °C 
were thawed at 4 °C, filtered (cellulose acetate filter, 0.8 µm) and applied with a flow-rate of 
2 ml/min to a protein G-sepharose affinity column (5 ml column volume) at 4 °C.  The 
column was washed with 10 column volumes of PBS and 10 column volumes of wash buffer 
(20 mM sodium phosphate pH 7.0). Bound antibody was eluted in an acid step (100 mM 
glycine, pH 2.7), immediately supplemented with 300 mM NaCl and adjusted to pH 7.5 with 
neutralising buffer (1 M Tris/HCl pH 9.0). All buffers were filtered (cellulose acetate filter, 
0.8 µm) prior to use. 
 
4.4.11 Purification of protein A-NCAM 
Recombinant protein A-NCAM was purified from the culture supernatant of stably 
transfected CHO-2A10 cells by IgG-affinity chromatography. 55 ml of cell culture 
supernatant stored at –20 °C were thawed at 4 °C, filtered (cellulose acetate filter, 0.8 µm) 
and applied at 4 °C with a flow-rate of 1 ml/min to an IgG-sepharose affinity column (column 
volume: 1 ml).  The column was washed with 15 ml buffer A (10 mM MES pH 6.8, 100 mM 
NaCl) and bound protein A-NCAM was eluted in an acid step (100 mM glycine, pH 2.7). The 
eluent was immediately supplemented with 200 mM NaCl and adjusted to pH 7.5 with 
neutralising buffer (1 M Tris/HCl pH 9.0). All buffers were filtered (cellulose acetate filter, 
0.8 µm) prior to use. The protein solution was concentrated to 80 µg/ml using a ‘VivaSpin’ 
centrifugal device (Vivascience, 3000xg, 4 °C) and stored at 4 °C.  
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4.4.12 Purification of ST8SiaIV∆25 
4.4.12.1 Myc-affinity chromatography 
Recombinant ST8SiaIV carrying a myc-His6-epitope at the C-terminal end was purified from 
the culture supernatant of baculovirus infected Sf9 cells by myc-affinity chromatography. The 
affinity matrix was generated as described in 4.4.7 by covalent coupling of mAb9E10 to 
protein G-sepharose (Amersham Biosciences). 500 ml of harvested Sf9 cell culture 
supernatant (4.3.5) were centrifuged (25 min, 7000xg, 4 °C), filtered (cellulose acetate filter, 
0.8 µm) and applied to the myc- affinity column (column volume: 2 ml)  with a flow-rate of 
1 ml/min at 4 °C. The column was washed with 45 ml buffer A (20 mM sodium phosphate pH 
7.5, 500 mM NaCl) and 25 ml buffer B (20 mM sodium phosphate pH 7.5). Bound enzyme 
was eluted in an acid step with elution buffer and immediately or stepwise adjusted to pH 7.5 
with neutralising buffer (1 M Tris/HCl pH 9.0). As elution buffers 100 mM glycine (pH 2.7-
4) and 100 mM citric acid (pH 3-5) were tested. All buffers were filtered (cellulose 
acetate filter, 0.8 µm) prior to use.  
4.4.12.2 Ni2+-chelating chromatography 
As the acidic elution conditions required for myc-affinity purification of ST8SiaIV∆25 
(4.4.12.1) resulted in partially denatured protein, a procedure for purification by Ni2+-
chelating chromatography was established and carefully optimised. 1000 ml culture 
supernatant of baculovirus infected Sf9 cells (4.3.5) were centrifuged (25 min, 7000xg, 
4 °C), filtered (Millipore, 0.22 µm) and concentrated to 100 ml using VivaFlow50 crossflow 
filtration units (PES membrane, 10 kDa MWCO) at 4 °C. To exchange the buffer and remove 
small molecular binding inhibitors, the concentrate was refilled with buffer A (20 mM MES 
pH 6.8, 75 mM NaCl) to 400 ml, concentrated again to 100 ml, once more refilled to 300 ml 
with buffer A (20 mM MES pH 6.8, 75 mM NaCl) and finally concentrated to 80 ml. The 
concentrated sample was filtered (Millipore, 0.22 µm) and after addition of 10 % glycerol 
incubated overnight at 4°C with 1 ml ‘ProBond’ Ni2+-matrix (Invitrogen). The following 
washing and elution steps were performed at room temperature using an ‘Äkta FPLC sytsem’ 
(Amersham Biosciences) at a flow rate of 2 ml/min if not otherwise indicated. All buffers 
were filtered (cellulose acetate filter, 0.8 µm) and degassed prior to use. The resin was 
subsequently washed with 15 ml buffer B (20 mM MES pH 6.8, 750 mM NaCl, 10 % 
glycerol, 20 mM imidazole) and 10 ml buffer C (20 mM MES pH 6.8, 75 mM NaCl, 10 % 
glycerol, 20 mM imidazole). The histidine-tagged protein was eluted in a linear imidazole 
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gradient (20-400 mM) composed of buffer C and buffer D (20 mM MES pH 6.8, 75 mM 
NaCl, 10 % glycerol, 400 mM imidazole). 1 ml fractions were collected throughout the 
purification. Peak fractions were pooled and immediately subjected to a desalting column 
(HiPrep 26/10, Amersham Biosciences) equilibrated in buffer A (20 mM MES pH 6.8, 
75 mM NaCl), to remove the imidazole from the protein samples. The column was eluted 
with buffer A at a flow rate of 3 ml/min. Protein fractions were pooled, concentrated to 
3 mg/ml using ‘VivaSpin’ centrifugal devices (Vivascience, 3000xg, 4 °C) and either flash 
frozen in liquid nitrogen or further purified by gelfiltration. 
4.4.12.3 Size exclusion chromatography 
Recombinant ST8SiaIV∆25 purified by Ni2+-chelating chromatography (4.4.12.2) was 
subjected to size exclusion chromatography for further purification. 300 µl of protein sample 
(3 mg/ml) were applied to a Superdex 200 HR 10/30 gelfiltration column (Amersham 
Biosciences) equilibrated in buffer A (10 mM MES pH6.8, 100 mM NaCl) and eluted at a 
flow rate of 0.75 ml/min (Äkta FPLC, Amersham Biosciences). The buffer was filtered 
(cellulose acetate filter, 0.22 µm) and degassed prior to use. Fractions of 1 ml were collected 
throughout the purification and analysed by silver stained SDS-PAGE. ST8SiaIV∆25 
containing fractions were pooled and concentrated to 2 mg/ml in ‘VivaSpin’ centrifugal 
devices (Vivascience, 3000xg, 4 °C). The concentrated samples were flash frozen in liquid 
nitrogen and stored at –80 °C. 
 
4.4.13 Purification of the N- and C-terminal fragment of endoNF 
4.4.13.1 Ni2+-chelating chromatography 
Recombinant endoNF carrying a StrepII-tag at the N-terminus and a His6-tag at the C-
terminus was expressed in E. coli BL21(DE3). The lysate (4.4.9) obtained from 1 l expression 
culture (4.4.8) was applied to a 5 ml HiTrap Chelating column (Amersham Biosciences, 
2 ml/min). The following washing and elution steps were performed at room temperature at a 
flow rate of 2 ml/min (Äkta FPLC, Amersham Biosciences) with filtered (cellulose 
acetate filter, 0.8 µm) and degassed buffers.  The column was washed with 15 ml buffer A 
(10 mM Tris/HCl pH 8.0, 300 mM NaCl) and eluted in two subsequent linear imidazole 
gradients from 0-100 mM and from 100-500 mM imidazole. 1 ml fractions were collected 
throughout the purification. The peak fractions of the first elution step containing the N-
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terminal fragment were pooled and further purified by StrepII-affinity. The pooled fractions 
of the second elution step containing the His6-tagged C-terminal fragment were subjected to 
gelfiltration for further purification.  
4.4.13.2 StrepII-affinity chromatography 
After separation of N- and C-terminal fragment of endoNF by Ni2+-chelating chromatography 
(4.4.13.1), the pool containing the N-terminal fragment was applied to a 5 ml StrepTactin 
affinity column (IBA) at a flow rate of 2 ml/min. The column was connected to the FPLC 
system (Äkta, Pharmacia), washed with 30 ml buffer W (100 mM Tris/HCl pH 8.0, 150 mM 
NaCl, 1 mM EDTA) and bound protein was eluted in a desthiobiotin step with buffer E 
(100 mM Tris/HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 2.5 mM desthiobiotin). Washing 
and elution step were performed at a flow rate of 2 ml/min. Protein containing fractions were 
pooled, subjected to a desalting column (HiPrep 26/10, Amersham Biosciences) equilibrated 
in buffer K (10 mM Tris/HCl pH 7.5, 100 mM NaCl) and eluted at a flow rate of 3 ml/min. 
Protein fractions were pooled, concentrated to 7 mg/ml using ‘VivaSpin’ centrifugal devices 
(Vivascience, 3000xg, 4 °C) and flash frozen in liquid nitrogen for storage at –80 °C. All 
elution and washing buffers were filtered (cellulose acetate filter, 0.8 µm) and degassed. The 
StrepTactin column was regenerated in two subsequent steps with buffer R (100 mM 
Tris/HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 mM hydroxyl-azophenyl-benzoic acid) and 
buffer W. Purifications from more than 500 ml expression culture exceeded the binding 
capacity of the StrepTactin column and the procedure was repeated with the flow through of 
the first run.  
4.4.13.3 Size exclusion chromatography 
The pool containing the C-terminal fragment after Ni2+-chelating chromatography (4.4.13.1) 
was concentrated to 8 mg/ml in ‘VivaSpin’ centrifugal devices (Vivascience, 3000xg, 4°C). 
Half of the sample (250 µl) was subjected to a Superdex 200 HR 10/30 gelfiltration column 
(Amersham Biosciences) equilibrated in filtered (cellulose acetate filter, 0.22 µm) and 
degassed buffer A (10 mM MES pH6.8, 100 mM NaCl) and eluted at a flow rate of 0.5 
ml/min (Äkta FPLC, Amersham Biosciences). The procedure was repeated with the second 
half of the sample. Fractions of 1 ml were collected throughout the purification and analysed 
by Coomassie stained SDS-PAGE. Fractions of the main peak were concentrated to 12 mg/ml 
(‘VivaSpin’, 3000xg, 4°C), flash frozen in liquid nitrogen and stored at -80°C. 
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4.4.14 Expression and purification of selenomethionine derivatised endoNF 
For the expression of selenomethionine derivatives the methionine auxotroph E. coli strain 
B834(DE3) was used. A 5 ml starter culture of E. coli B834(DE3) transformed with the 
respective expression plasmid (4.2.10) was grown over night in LB medium (200 µg/ml 
carbenicillin, 37 °C, 250 rpm). The bacteria were pelleted (10 min, 3000xg, 4 °C) and 
resuspended in 500 ml M9-medium (200 µg/ml carbenicillin) supplemented with 50 mg/l L-
methionine. The culture was grown at 37 °C and 250 rpm to an optical density of OD600 = 0.5 
and centrifuged (15 min, 3000xg, 4 °C). The bacterial pellet was resuspended in 500 ml M9-
medium (200 µg/ml carbenicillin) without methionine supplementation and the culture was 
incubated at 37 °C and 250 rpm for 20 min to exhaust intracellular methionine reservoirs. 
50 mg/l D-/L-selenomethionine was added and expression was induced after 30 min with 
1 mM IPTG. The bacteria were harvested after 3 h by centrifugation (10 min, 5000xg, 4 °C) 
and the pellet was stored at –20 °C.  
For purification of the recombinant protein the bacteria were lysed as described in chapter 
4.4.9. To avoid oxidation of the selenomethionine 10 mM DTT was added to buffer A. The 
N-terminal fragment of endoNF was then purified by StrepII-affinity chromatography as 
described in chapter 4.4.13.2 followed by Ni2+-chelating chromatography (4.4.13.1). After 
addition of 10 mM DTT the protein pool was applied to a desalting column (HiPrep 26/10, 
Amersham Biosciences) equilibrated in buffer K (10 mM Tris/HCl pH 7.5, 100 mM NaCl, 
10 mM DTT) and eluted at a flow rate of 2 ml/min. Protein fractions were pooled, 
concentrated to 14 mg/ml using ‘VivaSpin’ centrifugal devices (Vivascience, 3000xg, 4 °C) 
and flash frozen in liquid nitrogen for storage at –80 °C. 
 
4.4.15 ELISA-based polysialyltransferase assay 
The ELISA-based assay system (Stummeyer, 2000) schematically shown in Figure 6 is highly 
sensitive and reliable. The solid phase fixation of the enzymes allows the detection of 
polysialyltransferase activity directly from polysialyltransferase containing cell culture 
supernatants. Autopolysialylation can be measured separately, while the NCAM-
polysialylation signal results from polySia synthesized on both NCAM and enzyme. If, 
however, purified enzymes are used as enzyme source, also separate detection of NCAM-
polysialylation is enabled as the enzymes can be added in solution.  
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Figure 6: Schematic representation of the ELISA-based polysialyltransferase assay 
 
For solid phase fixation of enzyme and the polySia acceptor NCAM, 96-well microtiter plates 
(Greiner) were coated with 20µl/well of mAb 9E10 (5 µg/ml) diluted in PBS for 1 h at RT. 
Alternatively also the penta-His antibody (Qiagen) was used at 1 µg/ml. After blocking with 
200 µl blocking solution  (1 % BSA in PBS) for 1 h and two washing steps with PBS, the 
plates were incubated with 25 µl/well protein A-NCAM containing cell culture supernatant of 
transfected CHO-2A10 cells (4.3.2) for 1 h at RT. The plates were washed twice with PBS 
and the recombinant polysialyltransferase was adsorbed to the wells by incubation with 
enzyme containing culture supernatant of baculovirus infected Sf9 cells (25 µl/well, 1 h, RT). 
To measure exclusively autopolysialylation the incubation step with protein A-NCAM was 
omitted. After washing twice with PBS and once with reaction buffer (10 mM sodium 
cacodylate pH 6.5, 10 mM MgCl2), the enzyme reactions were initiated by addition of 25 µl 
reaction buffer containing 2 mM CMP-Neu5Ac and allowed to proceed for 3 h at 37 °C.  The 
reaction was stopped by washing the plates twice with PBS and synthesised polySia was 
detected by subsequent incubations with biotinylated Fab-fragments of the anti-polySia 
antibody mAb 735 (2 µg/ml, 1 h, RT) and streptavidine-conjugated peroxidase (0.3 µg/ml, 
30 min, RT) in blocking solution, each followed by two washing steps with PBS. Colour 
development was performed by incubating each well with 50 µl TMB-solution (0.2 mM 
citrate buffer pH 4.9, 0.1 mg/ml TMB, 0.0045 % H2O2) and stopped after 15 min by addition 
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of 25 µl 1 M H2SO4. The absorbance of the samples was measured at 450 nm using the 
ELISA-Reader ‘DigiScan’ (Asys Hitech).  
For separate detection of NCAM-Polysialylation with purified enzyme, the microtiter plates 
were instead coated with 20 µl/well mouse IgG (Pierce) at a concentration of 10 µg/ml in 
PBS. ProteinA-NCAM was adsorbed to the IgG coated plates as described above and the 
enzyme reactions were initiated by addition of 25 µl reaction buffer containing 2 mM CMP-
Neu5Ac and 5 µl of purified soluble polysialyltransferase. Synthesized polySia was detected 
as described above. 
 
4.4.16 Radioactive polysialyltransferase activity assay 
Enzymatic activity of recombinant polysialyltransferases was monitored by the incorporation 
of radiocarbon labelled Neu5Ac into polySia. Recombinant ST8SiaIV expressed in Sf9 cells 
was purified (4.4.12) and assayed in a soluble assay system while recombinant ST8SiaIV 
expressed in CHO-cells was adsorbed to IgG-coated sepharose beads and assayed as 
described in previously (Mühlenhoff et al., 1996a).  
For the soluble polysialyltransferase assay purified protein A-NCAM (4.4.11) was used as 
acceptor.  Assays were carried out in a final volume of 20 µl in reaction buffer (10 mM 
sodium cacodylate buffer pH 6.5, 10 mM MnCl2) containing 500 ng soluble NCAM-acceptor 
and 50-250 ng recombinant enzyme.  To analyse autopolysialylation, no acceptor was added 
to the samples, instead the amount of enzyme was increased at least 10 fold. The enzyme 
reactions were started by addition of 0.25 µCi CMP-[14C]Neu5Ac (10.4 GBq/mmol, 
Amersham Pharmacia Biotech) and allowed to proceed for 3 h at 37 ˚C. The samples were 
divided into two equal aliquots after the enzyme reaction and one aliquot was incubated with 
1 µl endoNE (56µg/ml) for 30 min at 37 °C as specificity control. The reactions were stopped 
by the addition of 2x Laemmli buffer and samples were analysed by 8 % or 10 % SDS-PAGE 
(4.4.2) followed by autoradiography.  
To analyse polysialyltransferases expressed in transiently transfected CHO cells as secreted 
protein A-fusionproteins (4.3.2), 1 ml of enzyme containing culture supernatant was 
incubated with 20 µl IgG-sepharose beads for 1 h at 4 °C. After one washing step in PBS the 
beads were incubated with 1 ml protein A-NCAM containing cell culture supernatant of 
transfected CHO-2A10 cells. The beads were washed three times in reaction buffer (10 mM 
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sodium cacodylate buffer pH 6.5, 10 mM MnCl2) and the enzyme reactions were started by 
the addition of 0.25 µCi CMP-[14C]Neu5Ac (10.4 GBq/mmol, Amersham Pharmacia Biotech) 
in a final volume of 40 µl reaction buffer. All samples were set up as duplicates. After 2 h at 
37°C, the reactions were stopped by washing twice with PBS and 20 µl 2xLaemmli buffer 
was directly added to half of the samples. As specificity control the second half of the 
samples was resuspended in 40 µl PBS, incubated with endoNE (60 ng, 30 min, 37 °C) and 
washed twice in PBS prior to the addition of 20 µl 2xLaemmli buffer. The samples were 
analysed as described for the soluble assay above. 
 
4.4.17 Quantitative endosialidase activity assay (TBA-assay)  
The TBA-assay (Skoza and Mohos, 1976) enables photometric quantification of vicinal OH-
groups present only at the free non-reducing end of sialic acids. As the non-reducing termini 
are increased upon digestion of polySia by endoNF, this method can be used to assay 
endosialidase activity. As polySia substrate colominic acid (Sigma) with an average degree of 
polymerisation of 16 (given by the manufacturer) was used.  
3.2 mg/ml colominic acid in sodium phosphate buffer (0.1 M, pH 5.1) was incubated with 
1/10 of the appropriate enzyme dilutions at 37 °C. Aliquots of 20 µl were taken in regular 
3 min intervals, mixed with 20 µl chilled 96 % ethanol and stored on ice. 140 µl of deionised 
water were added to the samples and the vicinal hydroxyl-groups were oxidized by incubation 
with 50 µl oxidising solution (23.5 mM HJO4 in 62.5 mM H2SO4) at 37 °C for 30 min. The 
reaction was stopped by the addition of 50 µl reducing solution (2 % NaAsO2 in 0.5 M HCl). 
Samples were mixed and incubated for 7.5 min at 95 °C after addition of 100 µl 6 % 2-
thiobabituric acid. 400 µl of DMSO were added and the absorbance of the samples was 
measured at 550 nm using the ELISA-Reader ‘DigiScan’ (Asys Hitech). Values were 
corrected for the amount of substrate associated non-reducing ends that were determined in 
the absence of enzyme. The amounts of free non-reducing ends in the samples were calculated 
from a standard curve with free sialic acid (0.5 – 5 µg).  
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4.4.18 ELISA-based endosialidase activity assay  
The ELISA-based endosialidase assay provides a rapid method to detect endosialidase 
activity. After incubation of polySia coated microplate wells with endoNF the remaining non-
cleaved substrate is detected by immunostaining using the polySia specific mAb 735. By end-
point dilution this assay allows to compare enzymatic activity of different endoNF samples. 
96-well microtiter plates (Becton Dickinson) were coated for 1 h at RT with 20 µl/well 
capsular polysaccharide purified from E. coli K1 (1 µg/ml in 10 mM sodium phosphate 
pH 7.4). After three washing steps in PBS the plates were blocked with 1 % BSA in PBS 
(200 µl/well, 1 h, RT). The plates were washed three times in PBS and incubated with 20 µl 
of the appropriate endoNF dilutions (100 – 2.000.000 fold diluted in PBS) for 30 min at 
37 °C. After three washing steps with PBS remaining polySia was deteted by subsequent 
incubations with mAb 735 (5 µg/ml, 1 h, RT) and peroxidase-conjugated secondary antibody 
(1:2000, 30 min, RT) in 1 % BSA in PBS, each followed by two washing steps with PBS. 
Colour development was performed by incubating each well with 20 µl ABTS substrate 
solution (Roche). The absorbance of the samples was measured after 15 min at 405 nm using 
the ELISA-Reader ‘DigiScan ’ (Asys Hitech).  
 
4.4.19 Crystallization procedure 
Protein samples for crystallization were thawed on ice, centrifuged (14.500xg, 15 min, 4 °C) 
and kept on ice during the preparation of the crystallization droplets. Crystallisation 
experiments were performed using the sitting drop vapour diffusion method. A drop 
composed of a mixture of 1 µl protein sample and 1 µl crystallization reagent was placed in 
vapour equilibration with a 500 µl reservoir of the crystallization reagent. The experiments 
were carried out in 24-well Cryschem plates (Hampton Research) sealed with Crystal Clear 
Sealing tape (Hampton Research) that were incubated at either 4 °C or 20 °C for crystal 
growth.   
Initial crystallization conditions were identified in sparse matrix screens and optimised by 
variations in pH, concentration of salts and precipitants or the addition of various additives. 
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5 Results 
5.1 The eukaryotic polysialyltransferase ST8SiaIV: Large scale 
expression, purification and crystallization trials  
The biological functions of the eukaryotic polysialyltransferases ST8SiaII and ST8SiaIV and 
of polysialylated NCAM, their synthesis product, are subjects of extensive international 
research efforts. PolySia-NCAM has been implicated in many physiological and pathological 
processes including the development of the central nervous system, neural regeneration and 
maintenance of  plasticity in the adult brain. In addition, recent studies in the field of tumour 
biology directly correlated polySia expression in tumours of neuroectodermal origin with high 
metastatic potential and poor prognosis. This makes the polysialyltransferases very promising 
drug targets for cancer therapy. Although extensively studied there is still limited knowledge 
about the biochemical properties of the polysialyltransferases and no structural data exist. The 
lack of structural information is mainly due to difficulties associated with the large scale 
production of recombinant polysialyltransferases. N-glycosylation was shown to be essential 
for the formation of active polysialyltransferases (Mühlenhoff et al., 1996a; Close et al., 
2000; Mühlenhoff et al., 2001) and when this study was started, the expression of active 
recombinant enzymes was only described for mammalian cell culture (CHO- and COS cells). 
The yields of recombinant protein obtained from the mammalian cell systems were, however, 
too small to enable protein characterisations by means of biophysical methods. Therefore, the 
first goal of this study was to evaluate the insect cell line Spodoptera frugiperda (Sf9) as an 
expression system for the vertebrate polysialyltransferases.  
 
5.1.1 Expression of the polysialyltransferase ST8SiaIV in insect cells  
Insect cells like Spodoptera frugiperda (Sf9) provide in combination with baculovirus 
expression vectors efficient expression systems for eukaryotic proteins. They are capable of 
performing posttranslational modifications like phosphorylation and N- or O-linked 
glycosylation. From earlier studies was known that replacement of the N-terminal 
transmembrane domain (TMD; see Figure 7) by a secretion signal leads to the expression of 
active, soluble polysialyltransferases in mammalian cell culture. Using this information, the 
5’-truncated cDNA (bp 76-1077) of the hamster ST8SiaIV was subcloned into the baculovirus 
shuttle vector downstream of a honeybee melittin secretion signal. The N-terminally truncated 
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recombinant protein (ST8SiaIV∆25) is schematically shown in Figure 7. It contains a myc-
His6-tag at the C-terminal end to facilitate detection and purification. 
 
Figure 7: Schematic representation of polysialyltransferase ST8SiaIV. Full length ST8SiaIV(wt) and the N-
terminally truncated ST8SiaIV(∆25). In the N-terminally truncated protein the transmembrane domain (TMD) is 
missing to allow expression of a secreted protein in Sf9 cells.  The large (L) and the small (S) sialylmotifs are 
highlighted as dark and light purple boxes, respectively. Asparagine residues involved in N-glycosylation are 
indicated. The N-glycan important for polysialyltransferase activity is marked with a filled circle. The myc-His6-
tag is shown as a green box. 
 
High titer stocks of recombinant baculovirus (BV-ST8SiaIV∆25) were generated as described 
in 4.3.4. For protein expression, Sf9 cells were grown to a density of 2x106 cells/ml and 
infected with the baculovirus stock (4.3.5). Expression of the recombinant proteins was 
analysed in a time-course over 96 hours by Western blot analysis.  To test the enzymatic 
activity of ST8SiaIV in the harvested cell culture supernatants, a recently developed sensitive 
ELISA-based assay was used (Stummeyer, 2000). Polysialyltransferases are protein specific 
glycosyltransferases that accept two polySia acceptors, which are the neural cell adhesion 
molecule NCAM and the polysialyltransferases themselves (Mühlenhoff et al., 1996a; Close 
et al., 1998). The two polysialylation reactions are further on referred to as NCAM-
polysialylation and autopolysialylation, respectively. The ELISA-based assay allows 
differential testing of either auto- or NCAM-polysialylation (Stummeyer, 2000). To assay 
autopolysialylation, the recombinant polysialyltransferase was immunoadsorbed to microtiter 
plates coated with anti-myc-tag antibodies. To assay NCAM-polysialylation, in a second step 
also Protein A-NCAM was adsorbed to the plates. PolySia-synthesis reactions were started by 
addition of CMP-Neu5Ac and polysialylated reaction products were detected with 
biotinylated Fab-fragments of the anti-polySia mAb 735 (for details see 4.4.15). The results 
are summarized in Figure 8. 
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Figure 8: Expression of catalytically active ST8SiaIV∆25 in Sf9 insect cells (A) Time course of the 
baculoviral expression of ST8SiaII∆25 in Sf9 cells. Culture supernatant of infected cells was assayed 24 h - 96 h 
after infection by 10% SDS-PAGE and Western blot developed with anti-myc antibody. The supernatant was 
either applied directly (1x) or after five fold concentration  (5x) by TCA-precipitation. (B) Enzymatic activity of 
cell culture supernatants determined by an ELISA based activity assay.  Samples were tested for NCAM- and 
autopolysialylation as shown by open and filled columns. Values are corrected by the negative control measured 
in the absence of CMP-Neu5Ac.  
 
As shown in the Western blot (Figure 8A) recombinant ST8SiaIV∆25 was expressed and 
secreted to the cell culture supernatant of baculovirus infected Sf9 cells. The protein was 
already detectable in the unconcentrated supernatant and reached a maximum expression level 
72 h after infection. Furthermore the ELISA based activity assay confirmed the enzymatic 
activity of the recombinant enzyme. A clear signal for NCAM-polysialylation was obtained 
48 h after infection that was maximal after 72 h but started to decreased 96 h after infection. 
Though the signals were not as high as for NCAM-polysialylation, also autopolysialylation 
was detectable. The course of the autopolysialylation activity corresponds to the course of 
NCAM-polysialylation. Because protein expression and activity peaked 72 h after infection, 
this time point was chosen to harvest the protein in subsequent experiments.  
The finding of autopolysialylation was surprising since earlier experiments carried out in 
CHO-cells had shown that autopolysialylation activity in ST8SiaIV depends on the presence 
of terminal galactose residues within the recombinant protein (Mühlenhoff et al., 1996a). Yet 
Sf9 cells are not believed to have the capacity to produce galactosylated N-glycans and lectin 
blot analysis carried out in this study with galactose specific lectins failed to identify 
galactosylted N-glycans on the insect cell expressed protein. However, it may be that a small 
proportion of enzyme in fact carries terminal galactose and a more detailed glycan analysis by 
e.g. mass spectrometry is necessary to answer the question. These kinds of experiments are 
planned for the near future.  
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In summary, these data demonstrate that the baculovirus mediated expression in Sf9 insect 
cells provides a suitable system for the recombinant production of polysialyltransferases. The 
obtained proteins were capable to perform NCAM- and autopolysialylation and were 
expressed in good yields. Following experiments concentrated therefore on the optimisation 
of protein production and the establishment of protein purification procedures. In all these 
studies ST8SiaIV was used as a model protein.  
 
5.1.2 Purification of ST8SiaIV from the culture supernatant of 
baculovirus infected Sf9 cells 
5.1.2.1 Purification by myc-affinity chromatography 
To facilitate purification, recombinant ST8SiaIV∆25 was C-terminally tagged with myc- and 
His6-epitopes and in small scale pioneering studies at first purification by myc-affinity 
chromatography was tested. Anti-myc affinity matrix was generated by covalent coupling of 
the anti-myc antibody 9E10 to protein G-sepharose (4.4.7). The test purifications shown in 
Figure 9 were performed in batch format. 100 µl of the anti-myc matrix was incubated for 1h 
with 50 ml ST8SiaIV∆25 containing cell culture supernatant. Beads were washed twice with 
PBS and bound protein was eluted under acidic conditions by resuspending the beads in 
300 µl elution buffer for 2 min. After centrifugation (1 min, 10000xg, 4 °C) the supernatant 
was adjusted to pH 7.0 with neutralizing buffer (1 M Tris/HCl pH 9.0).  
As depicted in Figure 9A ST8SiaIV∆25 was efficiently purified from the culture supernatant 
and appeared as homogenous band in a Coomassie stained gel. The enzymatic activity of the 
purified protein was confirmed by ELISA-based activity assay that clearly showed NCAM- 
and autopolysialylation activity (Figure 9B).  
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Figure 9:  Purification of ST8SiaIV∆25 by myc-affinity chromatography (A) Analysis of the myc-affinity 
purification of ST8SiaIV∆25 from the culture supernatant of baculovirus infected Sf9 cells by Coomassie stained 
10% SDS-PAGE and Western blot developed with anti-myc antibody. (B) Enzymatic activity of the purified 
enzyme analysed by ELISA-based polysialyltransferase assay. To test for NCAM-polysialylation protein A-
NCAM was adsorbed to IgG coated microtiter plates and the purified ST8SiaIV∆25 was added in solution. To 
test for autopolysialylation the purified ST8SiaIV∆25 was adsorbed to microtiter plates coated with anti-myc 
mAb. Control samples were tested in the absence of the substrate CMP-Neu5Ac.  
 
Based on these results an anti-myc affinity column was prepared for larger scale purification 
of the recombinant protein. Therefore, 20 mg of anti-myc antibody 9E10 were purified form 
hybridoma cell culture supernatant by protein G-affinity chromatography (4.4.10) and 
covalently coupled to 5 ml protein G-sepharose (4.4.7). The resulting anti-myc affinity matrix 
was used to purify ST8SiaIV∆25 from 500 ml supernatant of baculovirus infected cell 
culture.  
Although efficiently adsorbed to the affinity column, the recombinant protein precipitated 
shortly after elution and could not be re-dissolved. Because over-concentration of the protein 
sample was believed to cause the precipitation, the eluate was immediately diluted in the 
collection step. But precipitation occurred already for protein concentration below 100 µg/ml 
and could neither be prevented by step-wise nor by rapid change to neutral pH. Therefore, 
different buffer systems (Citrate, Phosphate, Tris) were tested for elution in a pH-range from 
2-8. Yet, they either failed to elute the protein or the eluted protein again precipitated. This 
systematic approach clearly demonstrated that buffer conditions required to breake the high 
affinity binding between the monoclonal antibody 9E10 and the myc-tagged protein are not 
compatible with the stability of the recombinant enzyme.  
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Also trials to stabilize the protein by addition of divalent cations such as Mg2+ or Mn2+ 
(putative cofactors of the transferases that might have been washed out during the acidic 
elution), had no effect.  
In summary these data allow to conclude that recombinant ST8SiaIV∆25 is at least partly 
denatured under the acidic pH-conditions needed to elute the enzyme from the myc-column. 
Myc-affinity chromatography is therefore not suitable to purify recombinant ST8SiaIV∆25 
for structural analysis, in particular crystallography, where correctly folded protein is required 
at high concentrations.   
 
5.1.2.2 Purification by Ni2+-chelating chromatography 
To avoid acidic elution steps during the purification of ST8SiaIV∆25 from the culture 
supernatant of baculovirus infected Sf9 cells, purification by Ni2+-chelating chromatography 
using the His6-affinity tag was tested. Initial studies were carried out with recombinant 
ST8SiaIV∆25 carrying the C-terminal myc-His6-tag as shown in Figure 7.  
Binding of diluted protein samples to a Ni2+-affinity column is in general not very efficient 
and was further hampered by the fact that media for insect cell culture are rich in components 
(e.g. amino acids) that compete for binding to Ni2+-agarose. Careful optimisation steps were 
therefore necessary, to evaluate the conditions for binding of ST8SiaIV∆25 to the Ni2+-
matrix. Trials to harvest the recombinant protein from the medium by ammoniumsulphate or 
polyethylenglycole (PEG) precipitation were not successful, as the precipitated protein could 
not be re-dissolved. Instead the culture supernatant was concentrated using a tangential cross 
flow filtration system and small binding inhibitors were removed by buffer exchange. The 
final purification procedure is described in detail in chapter 4.4.12. 
Parallel to the optimisation experiments a second baculovirus vector was generated that 
encoded the ST8SiaIV∆25 with an N-terminal His6-tag followed by an rTEv-protease site to 
facilitate removal of the affinity tag from the purified protein. This baculovirus was then used 
for the large-scale expression and purification of ST8SiaIV. 
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Figure 10: Purification of ST8SiaIV∆25 by Ni2+-affinity chromatography (A) Elution profile the of Ni2+-
affinity purification of ST8SiaIV∆25 from culture supernatant of baculovirus infected Sf9 cells. Absorbance at 
280 nm is shown as solid line, the imidazole elution gradient as dotted line. Peak fractions containing 
ST8SiaIV∆25 are filled in grey. (B) Protein fractions obtained through the purification were analysed by 
Coomassie (lower panel) and silver (upper panel) stained 10% SDS-PAGE as indicated. Arrows indicate bands 
that correspond to ST8SiaIV∆25. (sn) ten fold concentrated supernatant applied to the column, (flow thr.) 
flowthrough of the column.   
 
In Figure 10 the Ni2+-affinity purification ST8SiaIV∆25 from one litre of baculovirus infected 
Sf9 cells is shown. The protein eluted at 100 mM imidazole and appeared as homogenous 
band on a Coomassie stained SDS-PAGE, though the more sensitive silver staining revealed 
some contaminating protein bands (Figure 10B). Following the Ni2+-column the pooled 
fractions were subjected to a desalting step to remove the imidazole (4.4.12.2).  
 
Figure 11: Desalting of the ST8SiaIV∆25 pool after Ni2+-affinity chromatography (A) Elution profile of the 
desalting step following the Ni2+-affinity purification of ST8SiaIV∆25.  Absorbance at 280 nm is shown as solid 
line (protein), the conductivity as dotted line (salt). (B) Coomassie stained 10% SDS-PAGE of the concentrated 
ST8SiaIV∆25 pool after desalting. To analyse the purity of the sample 0.8, 1.5 and 4 µg of protein were applied 
per lane as indicated. 
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As depicted in Figure 11A protein and imidazole containing salt peak were well separated and 
the purified ST8SiaIV∆25 appeared nearly homogenous in a Coomassie stained gel (Figure 
11B). The protein sample was concentrated to 3 mg/ml and either further purified by size 
exclusion chromatography or flash frozen in liquid nitrogen and stored at –80 °C until used in 
crystallization trials. From a one-litre culture of baculovirus infected Sf9 cells a total of 
1.5 mg of purified ST8SiaIV was obtained. 
 
5.1.2.3 Enzymatic activity of recombinant ST8SiaIV∆25 purified from Sf9-cell culture 
The enzymatic activity of the ST8SiaIV∆25 containing fractions obtained during the 
purification by Ni2+-affinity chromatography (5.1.2.2) was assayed using the ELISA-based 
assay (4.4.15). The detection principle of the assay, based on immunostaining of synthesised 
polySia, does not allow to determine the CMP-Neu5Ac incorporation into polySia as molar 
quantity. Therefore the specific enzyme activity is described as absorbance per mg protein. To 
stay within the linear range of the assay, samples were diluted up to 500 fold. As shown in 
Figure 12 the specific polysialyltransferase activity (NCAM- and autopolysialylation) can be 
enriched by more than factor 100 during the purification. In parallel the protein content 
decreased in a similar range indicating the stability of recombinant ST8SiaIV∆25 under the 
applied purification conditions.  
 
Figure 12: Specific activity monitored throughout ST8SiaIV∆25 purification ELISA based activity assay: 
The enzyme alone or together with Protein A-NCAM was adsorbed to ELISA-wells and incubated for 3 h at 
37°C in the presence of CMP-Neu5Ac. Negative controls were incubated in the absence of CMP-Neu5Ac. 
Synthesized polySia was detected by immunostaining using ladled Fab fragments of the anti-polySia mAb 735. 
As enzyme source the fractions obtained throughout the purification of ST8SiaIV∆25 were used as indicated. 
Additionally the total protein content of the pools is given.  
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The purified enzyme was additionally assayed in a soluble system avoiding solid phase 
fixation of either enzyme or acceptor NCAM (4.4.16). In contrast to the ELISA-based assay, 
the soluble assay allows to visualize the length of the synthesized polySia chains. Due to the 
use of CMP-[C14]-Neu5Ac as sugar donor the synthesized chains are radioactively labelled 
and can be displayed by SDS-PAGE with following autoradiography.  
 
Figure 13:  (A) Soluble activity assay using ST8SiaIV∆25 purified from Sf9 insect cells. The purified 
ST8SiaIV∆25 (after desalting) was incubated for 16 h at 37 °C in the presence of CMP-[14C]Neu5Ac 
(autopolysialylation) and Protein A-NCAM (NCAM-polysialylation) as indicated. Half of the samples was 
treated with endoNE after the enzyme reaction.  Polysialylated proteins were displayed by SDS-PAGE followed 
by autoradiography. (B) Polysialyltransferase assay with recombinant Protein A-ST8SiaIV expressed in CHO-
cells. Enzyme and Protein A-NCAM where adsorbed to Ig-coated sepharose beads and further assayed as 
described in (A). 
 
As shown in Figure 13A, a broad radioactive signal that indicates the presence of 
radiolabelled polySia was observed for purified ST8SiaIV when incubated with Protein A-
NCAM and CMP-[C14]-Neu5Ac. Protein A-NCAM migrates in SDS-PAGE with an apparent 
molecular mass of 140 kDa. The addition of polySia chains by the polysialyltransferases 
influences the migration behaviour and causes a shift to higher apparent molecular masses. 
Thereby, the length of the synthesized polySia chains correlates with the extend of the shift. 
As specificity control, parts of the sample were treated with polySia-specific 
endoneuraminidase (endoNE) after the enzyme reaction (Figure 13A, lane2). Due to its 
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cleavage pattern endoNE leaves a residual stump of 5-7 sialic acid residues bound to the 
protein. Therefore the band at 140 kDa represents formerly polysialylated NCAM, whereas 
the second band at 55 kDa represents the enzyme itself. Trials to detect autopolysialylation in 
the absence of NCAM requested enzyme concentrations ten times higher (Figure 13A, lane3).  
The data presented in Fig. 7A demonstrate that the recombinant ST8SiaIV∆25 expressed in 
Sf9 cells is capable to perform NCAM- and autopolysialylation also in a soluble assay system.  
In order to compare the properties of recombinant ST8SiaIV expressed in insect and 
mammalian cells a Protein A-fusion protein of ST8SiaIV∆25 was expressed in CHO-cells. 
Prior to incubation with CMP-[C14]-Neu5Ac, enzyme and Protein A-NCAM were adsorbed to 
Ig-coated sepharose. The assay was carried out as described in (4.4.16). Results are depicted 
in Figure 13B. The resulting radioactive signals were similar to the pattern observed for the 
insect cell expressed ST8SiaIV, indicating that both recombinant enzymes synthesize polySia 
chains of comparable length.  
 
RESULTS 54
5.1.2.4 Size exclusion chromatography of Ni2+-affinity purified ST8SiaIV∆25 
Though the recombinant ST8SiaIV∆25 obtained after Ni2+-chelating chromatography and 
desalting appeared almost homogenous on a Coomassie stained SDS-PAGE (B), the more 
sensitive silver staining revealed contaminating protein bands (Figure 10B). For further 
purification, the protein sample obtained after Ni2+-affinity was concentrated to 3 mg/ml and 
subjected to size exclusion chromatography (4.4.12.3).  The resulting elution profile is shown 
in Figure 14. Homogeneously purified ST8SiaIV∆25 eluted in the main peak of the profile 
(fractions 14-18), well separated from contaminating proteins. However, significant amounts 
of ST8SiaIV∆25 eluted already in earlier fractions, possibly due to oligomerisation of parts of 
the protein or due to the formation of heterocomplexes with the contaminants. The fractions 
of the two main peaks of the elution profile (11-13 and 14-18) were separately concentrated to 
2 mg/ml, flash frozen in liquid nitrogen and stored at -80°C for later use in crystallization 
trials. 
 
Figure 14: Final purification of the ST8SiaIV∆25 by size exclusion chromatography. After Ni2+-affinity 
chromatography the ST8Sia∆25 containing fraction was further purified by gelfiltration. Eluted fractions were 
analysed by silver stained 10% SDS-PAGE. Bands corresponding to ST8SiaIV∆25 are indicated by an arrow. 
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5.1.3 Crystallization trials  
Crystallization trials with ST8SiaIV were performed using either the sample obtained after 
Ni2+-chelating chromatography (5.1.2.2) or after size exclusion chromatography (5.1.2.4). The 
sitting drop vapour diffusion method as described in chapter 4.4.19 was applied. Equal 
volumes of protein sample and crystallization solution were mixed in a small droplet and 
equilibrated by vapour diffusion with a reservoir of the crystallisation solution. 
Screenings at 20°C and at 4°C yielded finally small brownish coloured crystals for the Ni2+-
affinity purified sample (Figure 15). The crystals did however not diffract und failed to grow 
from further purified protein samples obtained after gelfiltration. Therefore three crystals 
were dissolved in Laemmli-buffer after two washing steps in reservoir solution and analysed 
by silver stained 14% SDS-PAGE. As shown in Figure 15 the detectable protein bands at 30 
and 25 kDa are too small to represent the polysialyltransferase. Instead two similar bands 
were identified in two fractions obtained after gelfiltration (Figure 15), corresponding to 
fractions 7 and 8 of the elution profile shown in Figure 14. As crystals grew from those 
fractions, the brownish crystals were clearly not ST8SiaIV∆25. Despite of extensive 
screenings in the course of this doctorial thesis no ST8SiaIV crystals have been obtained so 
far. 
 
Figure 15: SDS-PAGE of putative ST8SiaIV∆25 crystals (A) Crystals obtained from the Ni2+-affinity purified 
ST8SiaIV∆25 sample. (B) Dissolved crystals analysed by silver stained 14 % SDS-PAGE. Protein bands are 
indicated by arrows. (C) Separation of the crystallizing contaminants from the Ni2+-affinity purified 
ST8SiaIV∆25 sample by gelfiltration and analysis by silver stained 14 % SDS-PAGE.  
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5.2 Crystal structure of the polysialic acid degrading 
endoneuraminidase cloned from bacteriophage K1F 
 
In a second project efforts were focused on the structural analysis of polySia degrading 
enzymes, the endosialidases.  
Due to their high specificity for polysialic acid (polySia), bacteriophage derived 
endosialidases (endo-N-acetylneuraminidases, endoN) are widely applied in neurosciences 
and may find use as diagnostic or therapeutic tools for polySia bearing tumours and 
meningitis caused by polySia encapsulated bacteria. For example, E. coli K1 specific 
bacteriophages have been found to efficiently treat septicaemia and meningitis in infected 
mice and chicken (Smith et al., 1982; Barrow et al., 1998) and the application of the enzyme 
in a mouse model system was demonstrated to significantly reduce the metastatic potential of 
polySia bearing tumour cells (Daniel et al., 2001). Detailed understanding of the structure-
function relationships in endosialidases is of major importance to exploit the bio-medical 
potencies of these enzymes. While crystal structures have been determined for several 
exosialidases (Varghese and Colman, 1991; Tulip et al., 1991; Burmeister et al., 1992; 
Crennell et al., 1993; Crennell et al., 1994; Gaskell et al., 1995; Crennell et al., 2000) and 
their catalytical mechanism is well described (Chong et al., 1992), no structural data are 
available for endosialidases. Therefore the aim of this study was to determine the crystal 
structure of the polySia degrading endoNF. 
 
5.2.1 N-terminal truncations of endoNF 
Primary sequence alignments and BLAST searches (Altschul et al., 1997) performed with 
endosialidases revealed a chimeric composition of the enzymes with three putative domains 
(Figure 16).  Based on sequence homology to the tail fibre protein gp17 of coliphages T3 and 
T7 and the yersiniophage YeO3-12, the N-terminal part of endoNF was suggested to be the 
head-binding domain, attaching the endosialidase tailspike to the bacteriophage baseplate 
(Petter et al., 1993; Pajunen et al., 2000). The central part of the molecule is highly conserved 
in all endosialidases analysed so far and believed to comprise the catalytic domain. It is 
followed by a small C-terminal part (marked in red in Figure 16) that is cleaved off during 
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enzyme maturation and from our earlier work known to be essential for the formation of 
active endosialidases.  
It was already known from the crystallisation of the P22 tailspike, which was shown to have a 
similar domain organisation (Chen and King, 1991) that the full-length protein failed to 
crystallize. Crystals of P22 could only be obtained from an N-terminally truncated protein 
lacking the head-binding domain (Steinbacher et al., 1994). To identify the shortest 
catalytically active fragment of endoNF still capable to form SDS-resistant trimers, N-
terminally truncated forms (see Figure 16) were generated, recombinantly expressed and 
analysed with respect to both complex formation and enzymatic activity.  
 
 
Figure 16: Schematic representations of wild type (wt) and N-terminally truncated forms of endoNF. The 
region homologous to the gp17 head binding domain of coliphages T7 and T3 and yersiniophage YeO3-12 is 
depicted in yellow. The small C-terminal fragment shown in red is proteolytically cleaved off during maturation 
of the enzyme; the cleavage site is indicated by an arrow. All proteins are epitope tagged with an N-terminal T7-
tag (green box). 
  
The N-terminal truncations depicted in Figure 16 were expressed in E. coli BL21(DE3) as 
described in chapter 4.4.8. Soluble fractions of the bacterial lysates were analysed by SDS-
PAGE (4.4.2) and Western blot analysis (4.4.5). As shown in Figure 17A, N-terminal 
truncations of up to 245 amino acids resulted in the expression of soluble proteins and the 
observed molecular weights indicated that mutant proteins like the wild type protein were 
proteolytically processed. Further truncated proteins (∆270 and ∆338) were still 
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proteolytically cleaved, but the expression level was dramatically decreased. Complex 
formation was tested by omitting the boiling step prior to SDS-PAGE analysis. As shown in 
Figure 17B an appearing high molecular mass band indicates the presence of trimeric endoNF 
complexes. No complexes were visible in the case of ∆338-EndoNF while up to 270 amino 
acids could be removed from the N-terminus without effecting trimer formation.  
 
Figure 17:  Expression, complex formation and catalytic activity of wild type and N-terminally truncated 
endoNF forms. (A) Wild type and N-terminal truncated forms of endoNF were expressed in E. coli BL21 
(DE3). Soluble fractions of the bacterial lysates were analysed by 8% SDS-PAGE and Western blot that was 
developed with anti-T7 antibody. To compensate for differences in the expression rates, varying sample volumes 
were loaded as indicated. Bands corresponding to full length uncleaved endoNF and to the N-terminal fragment 
obtained after proteolytic processing are indicated. (B) Complex formation was analysed by 6% SDS-PAGE and 
Western blot as described in (A) but omitting the boiling step before electrophoresis. Bands corresponding to the 
SDS-resistant endoNF homotrimers are indicated. (C) Endosialidase activity of the soluble fractions (diluted 1:2 
in assay buffer) was assayed using the thiobabituric acid assay. Increasing absorbance at 550 nm corresponds to 
an increase of free non-reducing sialic acid moieties due to the enzymatic activity of endoNF. 
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Enzymatic activity of the truncated proteins was analysed by the thiobabituric acid (TBA) 
assay (4.4.17) using the soluble fractions as enzyme source. The TBA-assay (Skoza et al., 
1976) enables photometric quantification of vicinal OH-groups present only at the free non-
reducing end of sialic acids. As digestion of polymeric sialic acid by endoNF increases the 
number of non-reducing ends the TBA-test can be used to quantitatively assay endoNF 
activity. As shown Figure 17C removal of up to 245 amino acids from the N-terminus of 
endoNF did not interfere with the catalytic activity. Variations visible for the enzymatic 
activity are most likely due to the reduced expression rates (see Figure 17A). In contrast the 
mutants ∆270- and ∆338-EndoNF were functionally inactive. In summary, the analysis of the 
N-terminal truncated forms of endoNF revealed, that the first 245 amino acids of endoNF are 
not required for efficient expression, proteolytic processing, the formation of SDS-resistant or 
enzymatic activity.  
 
5.2.2 Expression and purification of recombinant endoNF 
As the aim of this study was to investigate the structure and function relationships of 
endosialidases by crystal structure analysis, large quantities of pure proteins were needed.  
Therefore in a first step expression and purification procedures had to be established to ensure 
sufficient protein supply.  
Endosialidases undergo proteolytic cleavage into a large N-terminal fragment harbouring the 
enzymatic activity and a small C-terminal fragment that is believed to function as an 
intramolecular chaperone (Mühlenhoff et al., 2003). The C-terminal fragment is essential in 
the nascent protein chain but after proteolytic release not part of the active trimeric complex. 
To enable the purification of both fragments, N- and C-terminal ends of endoNF were 
epitope-labelled with two different affinity tags. As depicted in Figure 18A two constructs 
were generated encoding the full length (EndoNF-SH) and a truncated endoNF with deleted 
head binding domain (∆245-EndoNF-SH). The purification procedure for both fragments is 
schematically shown in Figure 18B. The C-terminal fragment was purified by His6-affinity 
chromatography with subsequent size exclusion chromatography (gelfiltration) while the N-
terminal fragment was affinity purified using the StrepII-tag followed by a desalting step. 
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Figure 18: The purification strategy (A) Schematic representation of the full-length and N-terminally truncated 
endoNF constructs as overexpressed in E. coli. Recombinant proteins are epitope tagged. At the N-terminus a 
StrepII-tag (blue box) and at the C-terminus a His6-tag (green box) was added to allow the separate purification 
of the large N-terminal and the small C-terminal fragment, which are obtained after proteolytic cleavage of the 
full length proteins. The proteolytic cleavage site is indicated by an arrow. (B) Scheme of the purification 
procedures for the C- and the N-terminal fragments of endoNF.  
 
5.2.2.1 Ni2+-chelating chromatography: Separation of N- and C-terminal endoNF 
fragments 
Recombinant endoNF (EndoNF-SH) was overexpressed in E. coli (4.4.8). After bacterial lysis 
the soluble fraction was subjected to Ni2+-affinity purification as described in chapter 
4.4.12.2. Proteins adsorbed to the Ni2+-chelating column were eluted in two linear imidazole 
gradient steps from 0-100 mM imidazole and from 100-500 mM imidazole. The small C-
terminal fragment carrying a His6-tag eluted in a single peak at 300 mM imidazole (Figure 
19A).  
Because the bacterial lysates always contained a minor population of endoNF that was not 
proteolytically processed, the eluted fraction was not homogeneous. It contained 
contaminating full-length endoNF (carrying a His6-tag) and also detectable amounts of the 
large N-terminal fragment, that presumably co-purifies due to the formation of stable 
complexes with the full-length protein (Figure 19C).  
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Figure 19: Ni2+-affinity purification of endoNF (A) Elution profile of Ni2+-affinity chromatography of C-
terminally His6-tagged endoNF. Absorbance at 280 nm is shown as solid line, the imidazole elution gradient as 
dotted line. Peak fractions were analysed by Coomassie stained 10% SDS-PAGE (B) or 12% SDS-PAGE (C). 
Bands corresponding to full length uncleaved endoNF and to the N- and C-terminal fragments obtained after 
proteolytic processing are indicated. 
 
Purification of recombinant endoNF by Ni2+-chelating chromatography resulted in efficient 
separation of N- and C-terminal fragments (Figure 19A-B). Although not carrying a His6-tag, 
the N-terminal fragment was bound quantitatively to the Ni2+-column and eluted almost 
homogeneously at low imidazole concentrations (peak fractions 10 – 27 in Fig. 13 A). The 
two isolated protein fractions were further purified by gelfiltration or StrepII-affinity, 
respectively. 
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5.2.2.2 Purification of the catalytically active N-terminal fragment of endoNF  
The pool containing the N-terminal fragment of endoNF after Ni2+-chelating chromatography 
(5.2.2.1) was further purified by Strep-Tactin affinity chromatography as described in detail 
in chapter 4.4.13.2. The StrepII-tagged protein was adsorbed to the Strep-Tactin column and 
eluted in a desthiobiotin step gradient. As shown in Figure 20A the N-terminal fragment was 
purified to homogeneity after this second purification step. No contaminating bands were 
detectable on silver stained SDS-PAGE. As the N-terminal fragment is the catalytically active 
part of endoNF, the endosialidase activity was monitored during the purification procedure 
using the TBA-assay (4.4.17).  As shown in Figure 20B, the specific activity of the enzyme 
pools increased 4.5 fold during the purification while in parallel the total amount of protein 
decreased 4.5 fold. This clearly indicates that the enzyme is stable under the selected 
purification conditions. It also illustrates the power of the chosen expression system as the 
recombinant endoNF amounts to more than 20 % of the soluble protein of the bacterial lysate. 
Thus the subsequent purification of the catalytically active N-terminal fragment of endoNF by 
Ni2+-chelating and Strep-Tactin affinity chromatography resulted in homogeneously purified 
protein. From 1 l of bacterial expression culture 35 mg of catalytically active enzyme were 
obtained. After exchanging the buffer in a desalting step, the sample was concentrated to 
7 mg/ml, flash frozen in liquid nitrogen and stored at –80 °C for crystallization trials. 
 
Figure 20: Purification of the catalytically active N-terminal fragment of endoNF (A) Subsequent 
purification the N-terminal fragment of endoNF (prominent band at 103 kDa) analysed by silver stained 10% 
SDS-PAGE. (B) The catalytic activity of the protein pools obtained during the purification was monitored using 
the TBA-assay. One unit was defined as the amount of endoNF that produces 1 nmol of reducing ends per 
minute at 37°C and pH 5.1. Additionally the total protein content of the pools is indicated. 
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5.2.2.3 Purification of the C-terminal fragment of endoNF 
Purification of the C-terminal fragment of endoNF by Ni2+-chelating chromatography did not 
result in a homogeneous protein pool (5.2.2.1). It also contained full-length endoNF and parts 
of the N-terminal fragment. Therefore the pool was further purified by size exclusion 
chromatography as described in 4.4.13.3. As shown in Figure 15 efficient removal of the 
higher molecular weight forms could be achieved by this strategy. However, the separation of 
the small C-terminal fragment (22 kDa) from the significantly larger full length endoNF 
(125 kDa) or the N-terminal fragment (103 kDa), which additionally form stable trimers, was 
less pronounced than the huge differences in molecular mass suggested. Furthermore a minor 
fraction of the C-terminal fragment clearly co-eluted with the large fragments. Both facts 
suggest that also the C-terminal fragments aggregate to higher molecular mass oligomers.   
From 1 litre of bacterial expression culture 2.5 mg of homogeneously purified C-terminal 
fragment were obtained. The sample was concentrated to 12 mg/ml, flash frozen in liquid 
nitrogen and stored at -80°C until used for crystallization trials. 
 
Figure 21: Purification of the C-terminal fragment of endoNF by size exclusion chromatography The pool 
containing the C-terminal fragment after Ni2+-affinity chromatography was further purified by gelfiltration. 
Eluted fractions were analysed by Coomassie stained 14% SDS-PAGE. Bands corresponding to full length 
uncleaved endoNF and to the N- and C-terminal fragments obtained after proteolytic processing are indicated. 
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5.2.2.4 Purification of ∆245-EndoNF  
Analysis of the N-terminal endoNF truncations (5.2.1) had revealed, that up to 245 amino 
acids could be deleted from the N-terminus without severely effecting expression rate, trimer 
stability or enzymatic activity. For crystallization trials therefore also truncated endoNF 
(∆245-EndoNF-SH) was expressed and purified to homogeneity (Figure 21A) using the 
purification procedure described for the full-length protein (4.4.13). Like the full length 
endoNF also the truncated enzyme is highly stable under the purification conditions. The 
specific activity increased 6.6 fold during the purification while in parallel the total amount of 
protein decreased by the same factor. Considering the removal of 27% of the protein, the 
expression rates of full length and truncated endoNF and the specific activities of the purified 
samples are comparable. One litre of bacterial expression culture yielded 30 mg of the 
homogeneously purified ∆245-truncation. The protein was concentrated to 10 mg/ml, flash 
frozen in liquid nitrogen and stored at -80°C for use in crystallization trials. 
 
 
Figure 22: Purification of ∆245-endoNF (A) Coomassie stained 10% SDS-PAGE of ∆245-endoNF after the 
final purification step. To analyse the purity of the sample up to 50 µg of protein were applied per lane as 
indicated. (B) The catalytic activity of the protein samples was monitored during the purification procedure 
using the TBA-assay. One unit was defined as the amount of endoNF that releases 1 nmol of reducing ends per 
minute at 37°C and pH 5.1. Additionally the total protein content of the samples is indicated. 
 
RESULTS 65
5.2.2.5 Expression and purification of selenomethionine derivatised endoNF  
The crystal structure of endoNF was solved by multiwavelength anomalous dispersion 
(MAD). For this method crystals were needed from selenomethionine derivatised endoNF. To 
obtain a protein, in which the methionine residues were quantitatively exchanged by 
selenomethionine residues, the methionine auxotroph E. coli strain B834(DE3) was used for 
protein expression. As described in 4.4.14 the bacteria were grown in M9 minimal medium 
that contained selenomethionine as the only methionine source. The protein was purified by 
Strep-Tactin affinity chromatography followed by Ni2+-chelating chromatography to remove 
residual uncleaved endoNF that co-purified in the first step (4.4.14). To avoid oxidation of the 
selenomethionine most steps of the purification were performed under reducing conditions. 
As depicted in Figure 23 the selenomethionine derivatised enzyme is functionally active and 
forms SDS-resistant complexes. However, the specific activity decreased after the second 
purification step, indicating that the derivative might be less stable than the native protein. 
500 ml of bacterial expression culture yielded 7 mg of protein that was concentrated to 14 
mg/ml, flash frozen in liquid nitrogen and stored at -80°C. 
 
Figure 23: Purification a selenomethionine derivative of ∆245-endoNF (A) Coomassie stained 10% SDS-
PAGE displaying the purification of the selenomethionine derivatized N-terminally truncated catalytic fragment 
of endoNF. The protein provides the major fraction in the bacterial lysate and binds quantitatively to the Strep-
Tactin column. Homogeneously purified protein was obtained after Ni2+-chelating chromatography. Complex 
formation was analysed by omitting the boiling step before electrophoresis. Bands corresponding to monomeric 
endoNF and to the SDS-resistant trimeric complex are indicated. (B) The catalytic activity of the protein 
fractions analysed in (A) was monitored using the TBA-assay. One unit was defined as the amount of endoNF 
that produces 1 nmol of reducing ends per minute at 37°C and pH 5.1. Additionally the total protein content of 
the samples is indicated. 
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To check the incorporation of selenomethionine, the exact molecular mass of the recombinant 
protein was determined by ESI-TOF mass spectrometry. Each selenomethionine increases the 
molecular mass of the recombinant protein by 47 Da. The ESI-TOF analysis (cooperation 
with Dr. Detlev Suckau, Bruker Daltonik, Bremen) revealed a by 610 Da increased mass for 
the selenomethionine derivative (76514.2 Da; native protein 75904 Da). This mass difference 
is in perfect agreement with a complete replacement of the 13 methionine residues existing in 
endoNF with selenomethionine.   
 
5.2.3 Crystallization and data collection 
Crystallization trials were performed using the sitting drop vapour diffusion method described 
in chapter 4.4.19. Although extensively screened at 20 °C and at 4 °C no protein crystals were 
obtained for the full-length N-terminal fragment of endoNF (5.2.2.2). Also screenings with 
the C-terminal fragment (5.2.2.3) yielded no crystals. In contrast, well diffracting protein 
crystals were obtained for the truncated N-terminal fragment of endoNF (5.2.2.4) as shown in 
Figure 24. 
 
Figure 24: Crystallization of ∆245-endoNF (A) Crystals of the truncated (by 245 amino acids) catalytically 
active N-terminal fragment of endoNF. Colouring of the upper two pictures results from the use of a polarization 
filter. (B) Diffraction pattern of the crystals. The magnified panel illustrates the tight packing of the spots, which 
is due to the long axis of the unit cell (c= 346.7 Å). The resolution at the edge of the image is 1.8 Å.   
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Crystals were grown at 20°C in 4 µl droplets composed of 2 µl protein solution (10 mg/ml) 
and 2 µl crystallization reagent (14 % PEG3350, 0.2M LiSO4, 0.1 M Tris/HCl pH 7.5, 4 mM 
DTT). The crystals appeared after one week and reached a maximum size of 
100 x 100 x 1000 µm3 within four weeks. The crystals belonged to the space group P2221 
with unit cell dimensions of a = 99.7 Å, b = 131.3 Å and c = 346.7 Å. For data collection the 
crystals were soaked for 1 min in reservoir solution containing a cryoprotectant, mounted in 
cryo-loops and flash frozen in the nitrogen stream at 100 K. After careful optimisation of the 
cryoconditions (reservoir solution containing 10% 2,3-butanediol) native data to 1.9 Å were 
collected at the EMBL beamline 7B (DESY, Hamburg). Phase information necessary to solve 
the structure was obtained by multiwavelength anomalous dispersion (MAD). Therefore a 
three-wavelength dataset of a selenomethionine derivatized endoNF crystal was collected to 
3.1 Å at the EMBL beamline 7A (DESY, Hamburg). The selenomethionine derivative was 
expressed and purified as described in chapter (5.2.2.5) and crystallized in analogy to the 
native ∆245-endoNF. To understand the molecular basis for the highly specific binding and 
cleavage properties of endosialidases it was necessary to analyse complexes with bound 
substrate. Crystals of the ∆245-endoNF-sialic acid complex were obtained by soaking native 
crystals in precipitant solution containing 3 mM pentameric α2,8-linked sialic acid 
(Calbiochem) for 48 h at 20°C. Data of the complex were collected to 2.6 Å at the BESSY 
BL2-Beamline in Berlin.  
The collected data were processed and scaled either with DENZO/SCALEPACK (HKL 
Research) or MOSFLM (Powell, 1999)and SCALA (Bailey, 1994). The data statistics are 
summarized in Table 1. 
Data statistics 
 
Data set  
 
MAD 
 
Native 
 
(Di)sialic acid 
Wavelength [Å]: 0.9800  (Peak) 0.9802 
(Inflection) 
0.9736 
(Remote) 
0.8416 0.9195 
Space group:  P2221 P2221 P2221 
Cell dimensions [Å]: a = 100.1 
b = 131.8 
c = 348.3 
a =   99.7 
b = 131.3 
c = 346.7  
a =   99.5 
b = 131.4 
c = 346.0 
resolution [Å]: 3.15 1.90  2.55  
No. of reflections: 150407 149441 152359 335241 130540 
Completeness [%]: 98.7 (98.0) 97.1 (89.1) 99.9 (99.8) 93.7 (96.0) 88.4 (79.8) 
Rmerge: 0.066 (0.128) 0.062 (0.125) 0.079 (0.127) 0.103 (0.352) 0.107 (0.303) 
 
 
 
Table 1: Data statistics summarized for the three collected data sets. Rmerge = ΣhklΣi |Iihkl - < Iihkl>| / ΣhklΣi < Iihkl> 
where the sum i is over all separate measurements of the unique reflections hkl. 
RESULTS 68
5.2.4 Phasing, density improvement, and model building 
The crystal structure of ∆245-endoNF was solved by the multiwavelength anomalous 
dispersion (MAD) method. As the asymmetric unit of the crystals contained six monomers of 
∆245-endoNF each providing 13 selenomethionine residues a total of 78 selenium sites had to 
be found. All selenium atoms were located using the program SHELX-D (Sheldrick, 2001) 
and initial phases were calculated in SHELX-E (Sheldrick, 2001). Density modification by 
solvent flattening, histogram matching and phase extension was performed in DM (Cowtan 
and Zhang, 1999). The resulting map showed molecular bounders and allowed the recognition 
of secondary structural elements but could be significantly further improved by 
noncrystallographic symmetry (ncs) averaging. The ncs-operators symmetry relating the six 
monomers in the asymmetric unit were derived from the selenium sites using PROFESS 
(Bailey, 1994) while for the averaging again the program DM was used. The resulting map at 
1.9 Å was of good quality and interpreted by cycles of model building in O (Jones et al., 
1991) and Xtalview (McRee, 1992) and refinement using REFMAC (Bailey, 1994). To 
interpret the asymmetric unit first an initial Cα-trace for one monomer was build in O that was 
than used to generate also the Cα-traces of the remaining five monomers by symmetry 
transformations using the ncs-operators in MOLEMAN2 (Kleywegt, 1997). After rigid-body 
refinement in REFMAC the Cα-traces were converted into poly-alanine models and the amino 
acid side chains were build in XFIT (McRee, 1992). Again only one monomer was manually 
build, while the others were obtained by symmetry transformations. The model was refined 
using the maximum-likelihood algorithm implemented in REFMAC applying ncs-restraints 
and individual isotropic B-factor refinement. After three additional cycles of manual model 
building and refinement water molecules were included using ARP/wARP cycled with 
REFMAC. In later stages also TLS-refinement was used where each monomer was defined as 
one TLS-group. The final model contained all endoNF residues except the very C-terminal 
serine and one additional N-terminal serine that is part the affinity tag. This results in 3996 
Protein residues in the asymmetric unit that also contained 3075 water molecules and six 
phosphate ions. The final model refined to an R-factor of  16.6 % with a corresponding Rfree 
of 20.2 % over a 5 % test set of the reflections and good stereochemical quality. The 
refinement statistics are summarized in Table 2. 
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Refinement statistics 
 
Data set  
 
 
   
Native 
 
(Di)sialic acid 
R-factor [%]:    16.6 18.0 
Rfree [%]:    20.2 23.1 
No. protein atoms:    31380 31380 
No. of water molecules:    3075 926 
No. ligand atoms:    30 279 
Average protein B-value [Å2]:    14.2 21.0 
Average ligand B-value [Å2]:    36.9 40.3 
Average water B-value [Å2]:    27.3 28.1 
 
Ramachandran plot of non-glycine and non-proline residues 
 
most favourable regions: 
    
2885 (85.1 %) 
 
2857 (84.3 %) 
additionally allowed regions:      472 (13.9 %)   494 (14.6 %) 
generously allowed regions:        27   (0.8 %)     28   (0.8 %) 
disallowed regions:          6   (0.2 %)     11   (0.3 %) 
 
r.m.s. deviations from ideal values 
 
Bond distances [Å]:  
    
0.012  
 
0.015  
Angles [°]:    1.43 1.57 
 
Table 2: Refinement statistics  
R-factor = Σhkl| |Fobs| - | Fcalc| | / Σhkl|Fobs|  
Rfree as R-factor but summed over a 5 % test set of reflections. 
 
For the ∆245-endoNF complexed with sialic acid the structure factors calculated from the 
processed data of the complex were merged with the native model-phases. After refinement in 
REFMAC clear additional electron density for monomeric and dimeric sialic acid moieties 
bound to the enzyme was observed in the FO-FC-map. The ligands were build in O and the 
final model refined to an R-factor of 18.0 % with a corresponding Rfree of 23.1 % over a 5 % 
test set of the reflections. It included 3996 protein residues, 3075 water molecules, 6 
phosphate ions and six monomeric as well as three dimeric sialic acid ligands. The refinement 
statistics are summarized in Table 2. 
The coordinates of ∆245-endoNF as apoenzyme and in complex with substrate have been 
submitted to the Protein Data Bank (PDB). The accession codes are 1v0e for the apoenzyme 
and 1v0f for ∆245-endoNF complexed with sialic acid.  
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5.2.5 Structure description 
5.2.5.1 Overall structure of the catalytic fragment of endoNF (∆245-endoNF) 
The asymmetric unit of the crystals obtained from ∆245-endoNF contains six monomers. In 
agreement with the protein analytical studies (5.2.1) the monomers are arranged in two 
trimers. As shown in Figure 25A the trimers exhibit an overall mushroom-like outline that can 
be clearly separated in a stalk and a head region. Maximum dimensions are 100 Å in width 
and 115 Å in length.  
 
Figure 25: Structure of ∆245-endoNF (A) Ribbon stereo diagram of one of the ∆245-endoNF homotrimers 
present in the asymmetric unit. The three monomers are coloured red, blue and yellow.  (B) Structure of the 
∆245-endoNF monomer. The four domains that can be discerned in the monomer are indicated. The chain is 
coloured from blue at the N-terminus through to red at the C-terminus.  (C) Bottom view of the homotrimer with 
cross-section through its triangular tail domain. Ribbon diagrams were drawn with PYMOL (DeLano, 2002). 
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Each monomer folds into four distinct domains (Figure 25B). The three N-terminal domains 
assemble in the compact head whereas the C-terminal domain forms an extended tail-like 
structure. In the trimer the three tails intertwine to build an elongated stalk of 60 Å in length 
with triangular cross-section (Figure 25A, C). 
The mushroom head is dominated by a six-bladed β-propeller typical for sialidases (Taylor, 
1996). From the third blade of the β-propeller a nine-stranded β-barrel is branching off, which 
shows structural homology to the β-barrel domains of elongation factors and flavoproteins. 
Although the primary sequence identity is only 11%, the β-barrel structures of the E. coli 
elongation factor EF-Tu (PDB-entry 1EFC) and of endoNF can be superimposed with an 
r.m.s.d. fit of 2.6 Å.  
The very N-terminal part of the head structure (residues 246-322) holds the only α-helix of 
the entire 666 amino acid spanning protein. This is presumably the residual part of the deleted 
N-terminal domain (residues 1-245) proposed to be the head binding domain, which attaches 
the endosialidase to the phage tail (Petter et al., 1993; Pajunen et al., 2000). 
 
5.2.5.2 The head region: active site and polySia binding 
The six bladed β-propeller is known to be a characteristic structural feature of exosialidases. 
The structure is found in all bacterial, viral, and eukaryotic exosialidases solved so far. The 
propeller blades, each build by a four-stranded antiparallel β-sheet, are assembled around a 
central axis that passes through the active site cleft. While this overall topology is similar, the 
loop regions and the length of the β-strands differ between the respective exosialidases. The 
sialidase β-propeller of endoNF shows higher structural similarity to bacterial (Crennell et al., 
1993; Crennell et al., 1994; Gaskell et al., 1995) and eukaryotic (Luo et al., 1998; Buschiazzo 
et al., 2000) than to viral sialidases (Varghese et al., 1991; Tulip et al., 1991; Burmeister et 
al., 1992). The β-propeller domains of endoNF and a Trypanosoma rangeli sialidase 
(Buschiazzo et al., 2000) can be superimposed with an r.m.s.d. of 3.0 Å between 280 
equivalent Cα-atoms, indicating significant structural similarity. Common to all non-viral 
exosialidases are the short `Asp-box` motifs (SXDXGXTW) forming conformationally well 
conserved β-hairpins. The two Aps-box motifs found in endoNF are located between sheet 
three and four of the second and the fifth propeller blade. Superposition of the two β-hairpins 
including all main- and sidechains atoms of the eight residues results in an r.m.s.d. of 0.8 Å, 
illustrating their structural similarity.  
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However, the active site clefts located around the hub of the propeller differ between 
exosialidases and endoNF. Only three out of the six amino acids conserved in all known 
exosialidases are present in endoNF (Figure 26).  
 
Figure 26: Overlay of conserved active site features of exosialidases with the active site of endoNF. (A)  
Highly conserved active site residues of exosialidases are indicated and shown in grey stick representation. 
Exemplary a sialidase from Trypanosoma rangeli (PDB-entry 1mz6) is depicted with bound inhibitor DANA. 
The hydrophobic pocket accommodating the N-acetyl group of DANA is depicted as grey cartoon. (B) Overlay 
with the corresponding residues preserved in endoNF (green). The displaced hydrophobic pocket of endoNF is 
shown as green cartoon. 
 
Conserved are two arginines (Arg596, Arg647) and one glutamic acid (Glu581) residue. In 
exosialidases, the respective arginines are part of a conserved arginine triad involved in 
binding to the carboxylate group of sialic acid. The conserved glutamic acid together with a 
conserved tyrosine (missing in endoNF) is believed to stabilize the sialosylcation transition-
state intermediate proposed for the exosialidase reaction (Chong et al., 1992). Superposition 
of the conserved residues provides strong evidence that the substrate orientation in the active 
site of endo- and exosialidases is considerably different. Interestingly, the hydrophobic pocket 
accommodating the N-acetyl group of sialic acid is displaced by a rotation of 90° (Figure 
26B). This finding explains why trials to incorporate 2,3-dehydro-3-deoxy-N-
acetylneuraminic acid (DANA), a common active site ligand in exosialidase structures, into 
endoNF crystals either by soaking or in co-crystallization experiments failed. 
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Soaking endoNF crystals with pentameric α2,8-linked sialic acid and subsequent crystal 
structure analysis revealed that the nine-stranded β-barrel domain extending from the sialidase 
propeller is involved in polySia binding (Figure 27). A clear additional electron density 
corresponding to a disialic acid moiety identified a specific binding site within the β-barrel 
domain (Figure 27B). Due to differing accessibilities of the binding sites within the crystal 
lattice, bound disialic acid was observed for only three out of six monomers present in the 
asymmetric unit.   
 
 
Figure 27: PolySia bound to the β-barrel of endoNF (A) Bottom view of the homotrimer with cross-section 
through its triangular tail domain. An α2,8- linked sialic acid dimer bound to the blue β-barrel domain is shown 
in stick representation (B) Details of the disialic acid binding. Residues involved in sugar binding are labelled 
and according to the respective subunit coloured in blue or red. Dotted lines indicate hydrogen bonding 
interactions. The ligand is depicted in green sticks while the final electron density observed in a refined 2F0-Fc 
map contoured at 1 σ is represented as blue mesh. 
 
The bound disialic acid points with the non-reducing end towards the core of the trimer and 
the two α2,8-linked sialic acid moieties are anticlockwise twisted by 57°. Interaction is mainly 
mediated by Ser468 forming hydrogen bonds to one of the carboxylate oxygens of the sialic 
acid residue at the non-reducing end, to the oxygen of the glycosidic linkage, and to the 7-
hydroxyl oxygen of the sialic acid at the reducing end. Additional hydrogen bonds are 
established between the main chain nitrogen of Gly466 and the N-acetyl carbonyl oxygen of 
the reducing sugar as well as between Ser460 and the nitrogen in position C-5 of the sialic 
acid at the non reducing end, while the methyl function of the N-acetyl group is in 
hydrophobic contact with Thr728 and Tyr729. Both residues belong to the β-propeller of the 
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adjacent monomer, indicating that oligomerisation of endoNF is essential for enzymatic 
activity. This is further supported by the fact that the 22 Å distant active site cleft of the 
involved β-propeller could be reached by a pentameric substrate.  
The functional trimer is a rigid structure with low flexibility. In the trimeric head region 
(residues 246-786), contacts between the three monomers are mediated by more than 90 
intermolecular hydrogen bonds, mostly provided by the linkers connecting β-propeller and the 
tailspike domains, burying 25% of the monomer’s solvent accessible surface upon 
trimerisation. The mainly hydrophobic interface between β-barrel and β-propeller buries a 
total of ~920 Å2, corresponding to 17.5 % of the β-barrel and contains three interdomain 
hydrogen bonds. Thus, the catalytic domain of endoNF is assembled by stable intermolecular 
interactions between the polySia binding and cleaving domains of two adjacent monomers 
(Figure 28). 
 
Figure 28: EndoNF is a functional trimer (A) Surface representation of the trimeric head domain of endoNF. 
Bottom view with deleted trimeric stalk. The bound disialic acid and the position of the active site cleft are 
indicated.  (B) The magnified picture is rotated by 80° to illustrate the orientation of dimeric sialic acid towards 
the active site cleft in more detail. Conserved active site residues and the hydrophobic pocket are indicated.  
 
As illustrated in Figure 28 the topology of the active site cleft suggests the introduction of a 
sharp kink into the polySia chain upon binding. This would first of all favour the planar 
transition state proposed for the sialidase reaction (Chong et al., 1992). Besides that the 
introduced kink could move the carboxyl group of a vicinal sialic acid residue into a 
favourable position to substitute the carboxylate function of the missing aspartic acid residue 
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(Figure 26) that initialises the hydrolysis of the glycosidic linkage in exosialidases. This 
substrate-assisted catalysis could explain the strict substrate specificity of endosialidases for 
polysialic acid. The potential reaction mechanism of endoNF is discussed in more detail in 
chapter 6.2. 
 
5.2.5.3 The stalk region: intertwined subunits and sialic acid binding  
Intermonomeric interactions established already in the head region are further intensified in 
the trimeric stalk (residues 784-910) where the three C-terminal tailspike domains intertwine. 
Here a total of 62% of the monomer’s solvent accessible surface is buried in the trimer 
highlighting the intense intersubunit interactions in this domain. The stalk region folds in a 
triple β-helix that is interrupted by a small triple β-prism domain (Figure 25A). Both folds 
have recently been described for three bacteriophage tail proteins (Steinbacher et al., 1994; 
van Raaij et al., 2001; Kanamaru et al., 2002) and especially the triple β-helix has been 
accounted for the unusually stable trimers of these proteins. The trimeric stalk of endoNF 
exhibits an overall twisted appearance with a total twist of 120°. The triangular shaped 
interior contains no ordered waters and is exclusively hydrophobic except for one histidine 
(His874) involved in an interchain hydrogen bond to tyrosine 869. The inwardly pointing 
residues build six hydrophobic stacks extending over the whole length of the domain (Figure 
29B-C). Substantial networks of hydrogen bonds, intrachain in the prism-domain or 
interchain in the intertwined β-helical domains, additionally stabilize the stalk region.  
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Figure 29: Stabilizing interactions of the stalk region (A) Stereo ribbon diagram illustrating the network of 
interchain hydrogen bondings established in the triple β-helix domain. Hydrogen bonds are shown as green 
dotted lines while the main chain atoms of the three intertwined subunits are shown in red, blue and yellow, 
respectively. The depicted fragment of the stalk is indicated in panel C. (B) Top view showing the six 
hydrophobic stacks in the interior of the stalk.  Hydrophobic side-chains are coloured in orange. (C) Side view of 
the stalk domain. The hydrophobic site chains of one of the stacks (indicated with an arrow) are shown in 
orange. 
 
The first β-helical turn (residues 784-799) is similar to the β-helix domain found in the short 
tail fibre of bacteriophage T4 (van Raaij et al., 2001). Superposition of these sixteen 
equivalent Cα atoms results in an r.m.s.d. of 2.7 Å. The second helical turn (residues 800-
826), however, differs significantly from the first. The length of the β-strands increases from 
three to six residues and additionally a twist of 50° is introduced into the stalk. Both changes 
are mainly mediated by the more extended loop regions of this turn. The β-helical domain in 
the C-terminal region of the stalk (residues 871-910) appears less regular than the two N-
terminal turns. The faces of the triple β-helix are inwardly curved and the length of the β-
strands decreases from five to only two residues at the C-terminal end. In parallel, also the 
surface area of the triangular cross section decreases by 50 % and again a twist of 50° is 
introduced into the trimeric stalk. The small triple β-prism domain (residues 827-870) 
interrupting the two intertwined β-helix domains contains three antiparallel β-strands of five 
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residues each. The loop connecting the first β-helix to the β-prism domain and the loop 
between the first two strands of the β-prism both contain a three residue spanning 3/10-helix 
and expand vertically over the face of the β-sheet creating a shallow groove. Remarkably, this 
groove could be identified as second sialic acid binding site, for which well defined electron 
density of a bound single sialic acid molecule in β-conformation was observed for all six 
monomers in the asymmetric unit.  
 
Figure 30: Sialic acid binding site of the stalk region Side view of the stalk region with sialic acid residues 
shown in stick representation (green) bound to the three β-prism domains. The three monomers are coloured red, 
blue and yellow, respectively. Details of sialic binding are illustrated in the insert panel showing a magnified 
slightly rotated view of one binding site. Residues involved in sialic acid binding are labelled and according to 
the respective subunit coloured in blue or yellow. Dotted lines indicate hydrogen bonding interactions. The final 
electron density of the ligand observed in a refined 2F0-Fc map contoured at 1 σ is represented as blue mesh. 
 
This carbohydrate-protein interaction is mediated by hydrogen bonds of Gln853 to the 4-
hydroxyl oxygen and by main and side chain atoms of Ser848 to the 2-hydroxyl oxygen of the 
sugar. Furthermore the carbonyl oxygen of the sialic acid N-acetyl group hydrogen bonds to 
Arg837 while the methyl group is involved in hydrophobic interactions with Thr846 and 
Ile839 as well as Tyr821 that comes from a second subunit. Thus the trimeric stalk region of 
endoNF has not just dominant influence on the stability of the functional trimer, but is also 
directly involved in substrate binding. 
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5.2.6  Site directed mutagenesis of conserved active site residues of 
endoNF 
As shown in Figure 26 three active side residues of endoNF, a glutamic acid (Glu525) and 
two arginines (Arg596, Arg647), are conserved in all sialidases analysed so far. In initial 
mutagenesis studies, the conserved residues were exchanged to alanine by site-directed 
mutagenesis as described in chapter 4.2.12 and the mutant enzymes were expressed in E. coli 
BL21(DE3) (4.4.8). Soluble fractions of the bacterial lysates were analysed by SDS-PAGE 
(4.4.2) and Western blot analysis (4.4.5) and enzymatic activity was assayed using the 
ELISA-based endosialidase activity assay (4.4.18). The assay principle does not allow 
quantitative comparison of the enzyme activity but enables qualitative comparison at the basis 
of endpoint dilution.  
As depicted in Figure 31  all mutant enzymes are proteolytically cleaved and form SDS-
resistant trimers. The expression levels are comparable to the wild-type with exception of the 
mutant R647A that is expressed at detectable lower level. 
 
Figure 31: Site directed mutagenesis of conserved active site residues of endoNF (A) Wild type and mutant 
forms of endoNF were expressed in E. coli BL21(DE3). Soluble fractions of the bacterial lysates were analysed 
by 8 % SDS-PAGE and Western blot developed with StrepTactin directed against the StrepII-tag. 
 
Mutagenesis of the conserved active site residues decreased the activity of the mutant 
enzymes significantly (Figure 32). The wild-type fraction could be diluted at least 100 fold 
further than the three mutants E581A, R596A and R647A. In contrast mutation of the 
glutamic acid in position 525, which is located at the bottom of the active site cleft as direct 
neighbour of E581, had no influence on the enzymatic activity.  
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Figure 32: Enzymatic activity of mutant endosialidases (A) ELISA based endosialidase activity assay. 
Microplate wells coated with polySia were incubated with serial dilutions of the soluble fractions as indicated. 
The remaining non-cleaved substrate was afterwards detected by immunostaining using the polySia specific 
mAb 735. High absorbance values correspond to low enzymatic activity of the sample. 
 
In summary these data allow to conclude, that the three conserved active site residues are 
important for the enzyme reaction of endoNF, but none of the residues is essential, since all 
the mutant enzymes clearly exhibit activity. 
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6 Discussion 
6.1 The eukaryotic polysialyltransferase ST8SiaIV: Large scale 
expression, purification and crystallisation trials  
The presence of α2,8-linked polysialic acid (polySia) on the neural cell adhesion molecule 
(NCAM) modulates the cell-cell interactions during developmental processes and 
oncogenesis. The polySia expression of some human tumours of neuroectodermal origin 
could recently be directly correlated with high metastatic potential and poor prognosis (Daniel 
et al., 2001). Modulating polySia expression in the tumour situation is therefore an important 
goal and has moved the polysialyltransferases ST8SiaII and ST8SiaIV, the key enzymes in 
polySia synthesis, into the centre of therapeutic interest.  However, although extensively 
studied there is only limited knowledge about the biochemical properties of these enzymes 
and no structural information is available so far. The detailed analysis of structure function 
relationships in polysialyltransferases is mainly hampered by the lack of expression systems 
capable to supply sufficient amounts of active enzymes. The mammalian 
polysialyltransferases ST8SiaII and ST8SiaIV are glycoproteins, containing six and five N-
glycan attachment sites, respectively, and it has been shown that N-glycosylation plays a 
pivotal role for the catalytic functions of the enzymes (Mühlenhoff et al., 1996a; Close et al., 
2000; Mühlenhoff et al., 2001). Thus, trials to express the mammalian enzymes in protein-
glycosylation deficient organisms like E. coli resulted in the production of inactive proteins. 
On the other hand trails to express polysialyltransferases in glycosylation competent 
mammalian cell systems have so far been confronted with the problem of low yields. 
Therefore, the goal of this study was to evaluate the insect cell line established from 
Spodoptera frugiperda (Sf9 cells) as expression system for the mammalian 
polysialyltransferases. Hamster ST8SiaIV was used as a model protein in these studies.  
In insect cells high expression rates of recombinant proteins can be obtained, in particular in 
combination with baculovirus expression vectors. Insect cell are glycosylation competent (for 
review see (Altmann et al., 1999) though the produced glycan structures differ from the 
complex mammalian type N-glycans; for example, no terminal sialic acid residues and only 
very little, if any, galactose residues are found.   
Active polysialyltransferases can be expressed as secreted soluble proteins when the N-
terminal transmembrane domain is replaced by a secretion signal (Mühlenhoff et al., 1996a). 
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Therefore a recombinant baculovirus was constructed encoding the N-terminally truncated 
ST8SiaIV∆25 downstream of the honeybee melittin secretion signal (Figure 7). As shown in 
Figure 8, catalytically active ST8SiaIV was expressed and secreted to the culture medium of 
infected Sf9 cells. By ELISA-based activity assay the capability of the recombinant enzyme to 
perform NCAM- and autopolysialylation was clearly demonstrated (Figure 9B). The finding 
that ST8SiaIV expressed in insect cells was able to perform autopolysialylation was 
surprising, because earlier studies with polysialyltransferases expressed in CHO-cells had 
shown that autopolysialylation requires the presence of terminal galactose residues 
(Mühlenhoff et al., 1996a). Initial lectin analyses of Sf9 cell lysates and of recombinant 
ST8SiaIV expressed in these cells gave no indication for the presence of sialic acid or 
galactose (data not shown). Hence N-acetylglucosamine or potentially mannose might be the 
acceptors for the transferred sialic acid. However, the lectin analysis is not sufficiently 
sensitive to completely exclude that a minor fraction of ST8SiaIV is galactosylated and 
represents the autocatalytically active enzyme. More detailed glycan analysis by mass 
spectrometry will be necessary to characterize the polySia acceptor structures of insect cell 
expressed ST8SiaIV.   
As the ST8SiaVI∆25 was secreted in good quantities, a procedure to purify the recombinant 
enzyme from the culture medium of infected Sf9 cells was established. Though pioneering 
small-scale purifications of ST8SiaIV∆25 by myc-affinity chromatography (mAb 9E10) were 
promising (Figure 9A), the protein turned out to be unstable under the pH-conditions needed 
for elution from the myc-affinity column during the up-scaling studies. Purified protein 
fractions started to form precipitates shortly after elution and all trials to avoid the formation 
of insoluble precipitates failed. To circumvent these problems an alternative purification via 
His6-affinity chromatography was established. This technique avoids the acidic steps, which, 
by all likelihood, were responsible for protein denaturation. Instead His6-tagged proteins 
bound to a Ni2+-affinity column are eluted by increasing imidazole concentrations. As the 
binding affinity of the His6-epitope to the Ni2+-matrix is significantly lower than the myc-
9E10-affinity, trials to bind recombinant ST8SiaIV∆25 to the affinity matrix directly from the 
harvested supernatant failed. Careful optimisation steps were necessary to improve the 
binding conditions. The major problem in the loading step resulted from low molecular 
weight components of the insect cell culture media. These compounds competitively interfere 
with the His6-tagged protein for binding to the column. Therefore the harvested supernatant 
was concentrated ten fold and simultaneously the buffer was exchanged by tangential cross-
DISCUSSION 82
flow filtration.  This treatment allowed efficient binding of the recombinant protein to the 
affinity column and resulted in almost homogeneously purified protein in a single step 
(5.1.2.2). The resulting protein fractions could be concentrated to 10 mg/ml without 
detectable precipitate, indicating the higher stability compared to myc-affinity purified 
ST8SiaIV. Furthermore, the isolated enzyme was active. Additional purification by 
gelfiltration resulted in homogeneously purified ST8SiaIV (Figure 14).  
To compare processivity between CHO and insect cell expressed ST8SiaIV∆25 polySia 
chains produced by the respective enzymes were visualized in a radioactive 
polysialyltransferase assay. To visualize the chain length of the synthesized polySia, purified 
ST8SiaIV∆25was analysed in a radioactive polysialyltransferase assay were the synthesized 
radiocarbon labelled polySia is detected by autoradiography after separation by SDS-PAGE. 
As shown in Figure 13 the pattern of the observed radioactive signals are similar for 
ST8SiaIV∆25 expressed in Sf9 insect cells and in CHO cells, indicating that both enzymes 
synthesize polySia chains of comparable length. After specific degradation of polySia by 
endoneuraminidase, two distinct bands corresponding to formerly polysialylated NCAM and 
enzyme appeared, demonstrating NCAM- and autopolysialylation. Yet, to detect 
autopolysialylation of the insect cell expressed ST8SiaIV in the absence of NCAM, the 
amount of enzyme used in the radioactive assay had to be increased ten fold. Thus the 
autopolysialylation activity appears to be enhanced in the presence of NCAM. A similar 
phenomenon is described for some point mutants of ST8SiaVI after expression in CHO-cells. 
These mutants, which were inactive at the cellular level, could be transferred into active 
enzymes under in vitro conditions, if tested in the presence of NCAM. All enzyme forms that 
were active in vitro showed both NCAM- and autopolysialylation (Windfuhr et al., 2000). 
The mechanism of autopolysialylation is not understood and it is not clear at the moment, 
whether the visible automodification in fact represents a monomolecular real auto-catalytic or 
a bimolecular process. Thus, no more than a model view of how the automodification can be 
influenced by NCAM can be discussed (Figure 33). In case of a monomolecular self-
polysialylation reaction the enhancing effect of NCAM could be explained by a 
conformational change introduced into ST8SiaIV upon binding to NCAM that increases the 
transferase activity of the enzyme. Considering instead a bimolecular reaction mechanism for 
autopolysialylation, NCAM could have a stabilizing influence on the active homodimeric 
complex. 
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Figure 33: Model view on the enhancing influence of NCAM on the autopolysialylation reaction. (A) In 
case of a monomolecular autopolysialylation reaction: binding to NCAM (green) activates the moderately active 
ST8SiaIV monomers (purple). (B) In case of a bimolecular autopolysialylation reaction: binding to NCAM 
stabilizes the active homodimeric complex.  
 
In the ELISA-based polysialyltransferase assay, autopolysialylation activity can be detected 
without NCAM even if very diluted samples are used as enzyme source (e.g. supernatant of 
infected cell cultures). This may result from a higher sensitivity of the detection system, but 
could also be due to the solid phase fixation of the enzyme. The fixation forces a close and 
prolonged interaction between the bound molecules and could thereby stabilize oligomeric 
ST8SiaIV complexes. This would argue for a bimolecular rather than a monomolecular self-
modification reaction. However, additional data of kinetic studies are required to understand 
the enhancing effect of NCAM on the autopolysialylation activity of ST8SiaIV in more detail.  
Of major importance for the understanding of the polysialyltransferase reaction mechanism 
are detailed structural information as provided by a crystal structure. The expression and 
purification procedure established in this study yielded up to 2 mg of purified ST8SiaIV∆25 
per litre if Sf9-cell culture and therefore enabled the production of sufficient amounts of 
recombinant protein for crystallization trials. Crystallisation trials were performed with the 
homogeneously purified enzyme obtained after gelfiltration (see Figure 14) and with the near 
homogenous enzyme fraction obtained by His6-affinity chromatography (see Figure 10). 
However, for more than 1000 conditions tested in the course of this study no protein crystals 
of ST8SiaIV were obtained. Sparse matrix screening were performed either with the enzyme 
alone or together with the competitive inhibitor CMP. For future screenings also CDP, 
Neu5Ac, CMP-Neu5Ac or derivatives of those compounds could be added as crystallization 
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ligands. The recently crystallized bacterial sialyltransferase from Camphylobacter jejuni was 
crystallized in the presence of CMP-3FNeu5Ac (Chiu et al., 2004). The electronegative 
flourine atom at position C3´ prevents hydrolysis by inductively destabilizing the 
oxocarbonium ion-like transition state postulated for the reaction (Burkart et al., 2000). 
Moreover further truncated or engineered forms of recombinant ST8SiaIV could be tested. 
Recent studies in CHO-cells revealed that the N-terminus could be truncated by 60 amino 
acids without effecting enzymatic activity. The residual part of the stem region present in 
ST8SiaIV∆25 may be disordered and thus hamper crystallization. Also the five N-glycans 
attached to ST8SiaIV might interfere with the crystallization of the protein. It is known form 
parallel studies carried out in our laboratory that the engineered protein with only one residual 
N-glycan at position Asn74 (Figure 7) is active (Mühlenhoff et al., 2001). Initial trials to 
express the engineered enzyme in Sf9 cells indicated, however, significantly reduced 
expression levels compared to the wild type (data not shown). Still current efforts in the 
laboratory concentrate at up-scaling the production of this mutant.  
In summary, the effective two-step purification of polysialyltransferases from baculovirus-
infected insect cells (Sf9) facilitates the isolation of large quantities of homogeneously 
purified and enzymatically active polysialyltransferases. This forthcoming source of enzyme 
should enable structural studies that will provide valuable information regarding the 
molecular basis for substrate specificity and activity of the polysialyltransferases and support 
the search for polysialyltransferase inhibitors that are promising compounds for the treatment 
of polySia expressing tumours. 
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6.2 Crystal structure of the polysialic acid degrading 
endosialidase cloned from bacteriophage K1F 
Endosialidases (endo-N-acetylneuraminidases) are polysialic acid degrading tail spike 
proteins of bacteriophages infecting the human pathogen E. coli K1, which is encapsulated in 
a thick protective layer of polySia. To access the bacterial cell wall for infection K1 specific 
bacteriophages penetrate the polySia barrier using the depolymerising activity of their 
tailspikes (Figure 34). Endosialidases are the only known enzymes that bind and degrade 
polySia and are due to their high substrate specificity for polysialic acid essential and widely 
used tools in polySia research. The use of endosialidases enabled analysis of the biological 
functions of polySia in vertebrates without interfering with abundant mono- or disialylated 
structures. Recent studies in animal model systems demonstrated that endoneuraminidases 
interfere with the pathomechanism of polysialic acid encapsulated tumour cells (Daniel et al., 
2001). Thus the enzymes may also find use as diagnostic or therapeutic tool in the treatment 
of polySia bearing tumours. In contrast to exosialidases, where the catalytic mechanism is 
well described and several crystal structures are available (Varghese et al., 1991; Tulip et al., 
1991; Burmeister et al., 1991; Crennell et al., 1993; Crennell et al., 1994; Gaskell et al., 
1995) no structural data exist for endosialidases. The aim of this study was to analyse 
structure and function relationships in this group of polySia degrading enzymes. 
Several endosialidases have been cloned in the laboratory (Gerardy-Schahn et al., 1995; 
Mühlenhoff et al., 2003) and comparative protein expression studies carried out for the 
different enzymes demonstrated best yields for the endosialidase derived from bacteriophage 
K1 F. Therefore further studies concentrated on this protein.  
In the course of the protein expression studies the large tailspike protein (1064 amino acid 
residues) was found  to undergo proteolytic cleavage into a large N-terminal (residues 1-911) 
and a small C-terminal fragment (residues 912-1064). The N-terminal fragment harbours the 
enzymatic activity and forms unusually stable SDS-resistant trimers. Although the C-terminal 
fragment is released and not part of the active complex, the presence of this domain in the 
nascent protein chain was shown to be essential. While uncleaved proteins with mutated 
cleavage sites remained active and able to form trimers, trimer formation and enzymatic 
activity was completely abolished in C-terminally truncated proteins (Mühlenhoff et al. 
2003). Together these studies argue for an implication of the C-terminal domain in either 
folding or oligomerisation of the large N-terminal domain. Towards structural analysis the 
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expression of recombinant endoNF and the establishment of purification methods for both 
fragments were the first goals (Figure 18).   
The full-length endoNF - epitope tagged with a His6-tag at the C-terminal end and a StrepII-
tag at the N-terminal end - was expressed and proteolytically cleaved in E. coli BL21(DE3). 
For affinity purification of the C-terminal fragment the bacterial lysate was passed over a 
Ni2+-affinity column. Unexpectedly, also the N-terminal fragment bound quantitatively and 
eluted highly enriched at low imidazole concentrations (Figure 19). The fragment could be 
purified to homogeneity in a subsequent StrepII-affinity step (Figure 20) and was shown to be 
highly stable throughout the purification procedure by analysing the specific enzymatic 
activity of the obtained fractions (Figure 20).   The pool containing the C-terminal fragment 
after Ni2+-affinity was contaminated with full-length uncleaved endoNF and the N-terminal 
fragment (Figure 19C). Bacterial lysates always contained a minor fraction of endoNF that is 
not proteolytically processed und copurifies due to its His6-tag. The unexpected coelution of 
the N-terminal fragment results most probably from complex formation with the uncleaved 
protein. The C-terminal fragment was purified to homogeneity by size exclusion 
chromatography. Though the small fragment could be separated from the larger endoNF 
species, the separation was less pronounced than the difference in molecular masses implied. 
This finding strongly suggests that also the C-terminal fragment forms stable oligomers. The 
observed retention volume of the eluted protein in the gelfiltration suggests trimeric or 
tetrameric complexes of the C-terminal fragment.   
The expression and purification procedure for endoNF was efficient, yielding 35 mg of 
homogeneously purified N-terminal and 2.5 mg of the C-terminal fragment from one liter of 
expression culture. Both recombinant proteins were used in crystallization trials, however, so 
far no protein crystals were obtained.  
From crystallization studies carried out with the P22 tailspike protein was known, that the 
full-length protein did not produce crystals. In this case it was necessary to remove the N-
terminal part known to function as head-binding domain attaching the tailspike to the phage 
baseplate. The flexibility of the linker region connecting head-binding and spike domain in 
the P22 tailspike protein seemed to hamper the crystallization process. Because primary 
sequence analyses revealed a similar head-binding domain in endoNF, N-terminal truncations 
of endoNF were generated to define the minimal catalytically active unit. As shown in chapter 
5.2.1 up to 245 amino acids could be deleted from the N-terminus without severely affecting 
expression, enzymatic activity or trimer formation of the endosialidase. The truncated protein 
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(endoNF∆245) was purified as described for the wild-type and used in crystallization 
screenings. Well diffracting crystals were obtained after optimization of the initial 
crystallization conditions. The large unit cells dimension, in particular the length of the c-axis 
(346 Å), required careful optimization of the cryoconditions to obtain optimal diffraction 
patterns and separated spots. Yet high resolution data had to be limited to 1.9 Å to ensure 
sufficient spot separation.  
The endosialidase monomers (see Figure 25) exhibit a modular domain architecture. Four 
domains can be clearly distinguished: (i) a six-bladed β-propeller, (ii) a nine-stranded β-
barrel, (iii) the residual part of the head-binding domain and finally (iiii) an extended tail-like 
C-terminal domain. In agreement with the biochemical data (Mühlenhoff et al., 2003) the 
monomers assemble into a stable trimer (two trimers were found in the assymetric unit). The 
C-terminal tail-like domains build the remarkable elongated stalk of the trimer, whereas the 
N-terminal domains assemble to its compact head.  
The six bladed β-propeller is a characteristic structural feature of exosialidases, found in 
enzymes of bacterial, viral or eukaryotic origin (Taylor, 1996). The sialidase β-propeller of 
endoNF shows higher structural similarity to bacterial (Crennell et al., 1993; Crennell et al., 
1994; Gaskell et al., 1995) and eukaryotic (Luo et al., 1998; Buschiazzo et al., 2000) than to 
viral sialidases (Varghese et al., 1991; Tulip et al., 1991; Burmeister et al., 1991) and 
contains to Asp-box motifs. The biological function of the conserved ‘Asp-box’ motifs 
(SXDXGXTW) found in all non-viral exosialidases is unclear. As they are located on the 
propeller surface remote from the active site, contributions to the catalytic reaction are 
unlikely. Moreover Asp-boxes have been identified in at least eight distinct protein families in 
different structural contexts (Copley et al., 2001).  The evolution of short conserved peptide 
sequences, including also P-loop and helix-hairpin-helix motif, is not yet understood. Under 
discussion are either divergent or convergent evolution of the motifs or a possible function as 
ancient peptide ancestors for proteins with otherwise different folds (Copley et al., 2001). 
The nine-stranded β-barrel extending from the sialidase propeller is involved in polysialic 
acid binding. In endoNF crystals soaked with pentameric sialic acid, a dimer of α2,8-linked 
sialic acid was found bound to this domain. The presence of a sialic acid dimer rather than a 
pentamer seems to be a consequence of enzymatic cleavage in the crystal.  Though 
endosialidases most effectively cleave sialic acid polymers longer than seven residues, for 
high enzyme to substrate ratios and prolonged incubation times cleavage of shorter fragments 
has been reported (Hallenbeck et al., 1987; Pelkonen et al., 1989).  
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The substrate complex revealed that endoNF is a catalytic trimer. Already the binding of the 
dimeric sugar involved two subunits of the trimer (Figure 27). Furthermore, the arrangement 
of binding (β-barrel) and cleaving (β-propeller) units within the monomer excludes a direct 
interaction of a bound ligand with both domains. Instead interactions with the respective 
domains belonging each to adjacent subunits of the trimer are very likely. Though also for 
viral exosialidases the formation of dimeric or tetrameric oligomers is described, 
oligomerisation is most likely not of functional relevance as substrate binding and hydrolysis 
occur within one subunit.  
The functional trimer is stabilized by numerous intersubunit interactions. Already in the head 
region intersubunit hydrogen bonds and hydrophobic interactions are established and a total 
of 25 % of the solvent accessible surface is buried upon trimerisation. However, dominant 
influence on the remarkable stability of the endoNF homotrimer has the trimeric stalk region 
folding in a triple β-helix that is interrupted by a small triple β-prism domain (Figure 25A). 
Here a total of 62 % of the solvent accessible surface area is buried upon trimerisation and 
extensive networks of hydrogen bondings as well as stacking interactions of the hydrophobic 
interior of the stalk stabilize the trimer. The triple β-helix motif were the three intertwining 
subunits wind around the three-fold rotation axis of the trimer, has so far been described 
exclusively for proteins associated with the tail apparatus of bacteriophages. The tailspike of 
the salmonella phage P22 contains one tight β-helical turn (Steinbacher et al., 1994) whereas 
the protease stable fragment of the short tail fiber of the T4-phage crystallized by Raaij 
revealed two full turns of a triple β-helix (van Raaij et al., 2001). The longest β-helix motif is 
described for the tail lysozyme complex of the T4-page with seven full turns. The extended 
needle like prism is supposed to act as cell puncturing device that penetrates the bacterial cell 
wall and functions as injection needle for the phage DNA. A similar function of the endoNF 
stalk domain is unlikely as the stalk is exclusively hydrophobic and in contrast to the T4-
complex not hollow. Common to all three proteins is their ability to form unusually stable 
trimers. The trimer stability is most likely to a large extend mediated by the intertwined 
chains of the triple β-helix motifs as they enable extensive hydrogen bonding between the 
chains and the formation of a hydrophobic core common to all three chains. However, the 
intertwined topology and the many interchain interactions stabilizing the triple β-helix fold, 
raise the question how these homotrimers assemble from their monomeric subunits. For the 
P22 tailspike is known, that partly folded monomers associate into pro-trimer intermediates, 
which then undergo further conformational changes to form the SDS-resistant trimers. In 
contrast, the short T4-tail fiber, which has a more extended triple β-helix than P22, needs the 
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phage encoded chaperone gp57 for folding in vivo (King and Laemmli, 1973) and in vitro 
(Burda and Miller, 1999). Correct folding of endoNF requires the presence of the C-terminal 
domain in the nascent protein chain (Mühlenhoff et al., 2003), that might have a similar 
function as the gp57 and act as intramolecular chaperone or oligomerisation domain. 
Homologous regions to the C-terminal domain of endoNF were identified also in several 
other bacteriophage tail fiber proteins (Mühlenhoff et al., 2003), indicating that the concept of 
an intramolecular C-terminal chaperone or oligomerisation domain might be commonly used 
for the folding of phage tail fibers. 
Besides the triple β-helix found in bacteriophage tail associated proteins, another motif of 
intertwined β-strands has been described for fibrous proteins of two human viruses. The fiber 
of adenovirus Ad2 (van Raaij et al., 1999) and the attachment protein σ1 of reovirus T3D 
(Chappell et al., 2002) both contain a triple β-spiral motif. Also this motif mediates the 
formation of stable trimers. For the reovirus attachment protein σ1 it is additionally known 
that the host chaperone hsp70 is essential for correct folding of its triple β-spiral domain 
(Leone et al., 1996).  
Moreover, the  σ1 protein contains a sialic acid binding site in its fibrous tail as has been 
shown by mutagenesis studies (Chappell et al., 1997). Structural data for the sialic acid 
binding part of σ1 are not available to date. Most interestingly also the endoNF stalk domain 
functions not only as stabilizing unit for the functional trimer but is directly involved in sialic 
acid binding. The substrate complex revealed a sialic acid monomer bound to the stalk region 
of endoNF. The shallow binding pocket is provided by the small triple β-prism domain 
interrupting the two triple β-helix domains of the stalk.  
Recognition and processing of oligomeric substrates by enzymes frequently involves 
extended binding sites that can be considered as a series of subsites each binding to a single 
substrate moiety. Hence, the observed sialic acid binding sites in the β-barrel and the stalk 
region of endoNF can be regarded as high affinity subsites able to bind short dimeric or even 
monomeric sialic acid. Although the sialic acid bound to the stalk binding site is in β-chair 
conformation, the favored conformation of sialic acids in solution, the structure suggests that 
also α-conformation would fit into the binding site, implying that a polysialic acid molecule 
could simultaneously interact with the stalk, the ß-barrel, and the catalytic pocket of endoNF. 
Considering this aspect, polySia binding by endoNF involves a large portion of the protein 
and all three subunits of the homotrimer. Moreover, the polySia-endoNF interactions could be 
further stabilized by contacts to low affinity subsites not capable of binding short polySia 
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fragments. This multivalent binding would establishes stable interactions between the phage 
and the host capsule, in particular because probably six of the trimeric endoNF tailspikes are 
attached to the bacteriophage baseplate.  
The interactions between the endoNF tailspike and polySia are not only necessary for the 
depolymerization of the capsule, but apparently also crucial for the infection process of 
bacteriophage K1F: capsule-negative mutants of E. coli K1 are resistant against bacteriophage 
infection (Whitfield et al., 1984; Pelkonen et al., 1992). Starting from this observation it can 
be hypothesized that the short oligosialic acid remnants left after capsule depolymerisation are 
important for fixation of the phage particle to the host membrane. It is most likely that the 
stalk region of endoNF, being closest to the bacterial membrane, mediates this binding 
(Figure 34). The trimeric stalk domain seems to have developed as a most efficient device in 
the host recognition, attachment and infection process.  Studies are planed to directly analyze 
the impact of the spike domain on the enzymatic activity and kinetic properties of endoNF. 
 
 
Figure 34: Functions of the endoNF tailspike (A) The bacteriophage (orange) penetrates the polySia capsule of 
E. coli K1 using the depolymerising activity of its endoNF tailspike. Each of the six tailspikes (three are 
depicted) can bind and degrade three polySia chains. (B) The short oligoSia remnants left after capsule 
depolymerisation are bound by the stalk region of the tailspike thereby ensuring tight fixation of the phage to the 
bacterial membrane.  
 
All exosialidases crystallized so far, share conserved active site features Figure 26. In 
particular six amino acids are strictly conserved and have been implicated in the reaction 
mechanism proposed by Chong and colleagues. An arginine triad is binding to the carboxylate 
function of sialic acid. The interaction distorts the chair conformation of the pyranose ring 
that is preferred in solution into an α-boat conformation. Due to this strained conformation, 
where the ring atoms C2, C3 and O6 are coplanar, the cleavage of the glycosidic linkage and 
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the formation of a planar oxocarbonium ion that has been identified by kinetic isotope effect 
experiments are favored (Chong et al., 1992).  Hydrolysis of the glycosidic linkage is 
proposed to be initiated by a conserved aspartic acid acting as proton donor. Two conserved 
residues at the bottom of the active site cleft, a glutamic acid and a tyrosine, are believed to 
stabilize the cationic transition state. Hydroxylation of the oxocarbonium ion is then mediated 
by a water molecule, which is activated by the conserved aspartic acid now acting as general 
base. However, for the Trypanosoma cruzi trans-sialidase and the exosialidase of 
Micromonospora viridifaciens an alternative mechanism involving a covalent sialyl-enzyme 
intermediate has been postulated (Watts et al., 2003). According to that mechanism, the 
conserved Glu/Tyr couple at the bottom of the active site cleft acts as catalytic nucleophile. 
The tyrosine is relaying charge form the glutamic acid residue and by attacking the C2 atom 
breaks the glycosidic linkage to form the covalent intermediate. The sialyl-enzyme 
intermediate is then hydrolyzed by the nucleophilic attack of a water molecule activated by 
the conserved aspartic residue. All exosialidases analyzed so far are retaining glycosidases 
keeping the anomeric conformation in the primary hydrolysis product, which then undergoes 
mutarotation to the favored β-conformation. In case of the proposed SN1-mechanism 
including the sialosylcation intermediate, retention of the configuration is mediated by the 
tyrosine residue that shields the β-face of the sialosyl-moiety from water. Also the postulated 
double displacement mechanism involving two subsequent SN2-reactions, the first with 
nucleophilic attack from the β-face and the second with attack from the α-face retains 
conformation. 
 
Figure 35: Proposed reaction mechanism of exosialidases (A) Generalized two-step SN1-mechanism 
proposed  for most exosialidases. The indicated conserved tyrosine and glutamic acid stabilize the sialosylcation 
intermediate. The catalytic aspartic residue acts as general base. (B) Double replacement mechanism including a 
covalent sialyl-enzyme intermediate proposed for T.cruzi trans-sialidase and M.viridifaciens sialidase. The 
conserved tyrosine acts as nucleophile. 
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Remarkably only the conserved glutamic acid (Glu581) and two of the arginines (Arg596, 
Arg647) are preserved in endoNF. In contrast to exosialidases that cleave off terminal sialic 
acid residues (exo), endosialidases cleave within a polymeric sialic acid chain (endo). The 
topology of the active site clearly indicates, that a sharp kink needs to be introduced into the 
polySia chain to fit the polymer into the active cleft. This kink would be formed by a distorted 
α-boat conformation of the residue bound to the active site that would additionally favor the 
planar sialosyl transition state. In contrast to exosialidases, stabilizing protein-carbohydrate 
interactions can be established to neighboring sugar residues on either side of the cleavage 
point. This might explain why the arginine triad, presumed to enforce the unfavorable planar 
transition state in exosialidases, is not fully conserved in endoNF.  Mutation of either of the 
two remaining arginine residues resulted in a decrease though not a complete loss of 
enzymatic activity (5.2.6).  
Most importantly the aspartic acid and the tyrosine, both critical residues in either of the two 
proposed exosialidase mechanisms, are not conserved in endoNF. Mutagenesis of the tyrosine 
residue resulted for the analyzed viral sialidases and trans-sialidases either in misfolded 
proteins or enzymes with dramatically decreased activity (Lentz et al., 1987; Cremona et al., 
1995; Ghate and Air, 1998). For the Clostridium perfringens small sialidase, mutation of this 
tyrosine to phenylalanine resulted in inactive enzyme (Kleineidam et al., 2001), while 
mutation to isoleucine retained the active protein. A recent study carried out with 
Micromonospora viridifaciens sialidase has demonstrated that mutants whose critical tyrosine 
residue is replaced by alanine, aspartic acid, or glycine exhibit residual activity (Watson et al., 
2003). However, these mutants were no longer retaining but became inverting sialidases. The 
authors discuss that the replacement of tyrosine with smaller amino acids results in additional 
free space at the β-face of the bound sialic acid that can be occupied by a water molecule 
acting as nucleophile in either an SN2 or SN1 reaction. In case of the SN2 reaction the 
conserved glutamic acid would function as general base and activate the hydrolyzing water. 
Considering an SN1 reaction the conserved aspartic acid would initialize the formation of the 
sialosylcation that could then be trapped by a water molecule located at the β-face. 
In the active site of endoNF the position of the missing tyrosin is occupied by a glutamine 
residue. The glutamine residue and the conserved glutamic acid do indeed hydrogen bond to 
an ordered water molecule (clearly visible in the final Fo-Fc-map) that could act as 
nucleophile. In a mutagenesis approach the conserved glutamic acid residue was changed to 
alanine. The resulting mutant exhibits decreased but clearly detectable enzymatic activity. 
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 The catalytic aspartic residue acting as acid catalyst in a potential SN1 reaction is missing in 
endoNF. Considering the kicked acidic polySia substrate is it, however, possible that instead 
the carboxyl function of an adjacent sialic acid residue substitutes for the missing acidic 
amino acid. As it is not known to date if endosialidases are retaining or inverting 
glycosidases, the oxocarbonium intermediate could be hydroxylized by a water molecule from 
the β-face or the α-face of sialic acid. This model of a substrate assisted catalysis of 
endosialidases would also explain the lack of detectable exosialiase activity and the strict 
polySia specificity observed for endosialidases. 
 
 
Figure 38:  Two possible catalytic mechanism for endoNF (A) Substrate assisted catalysis model for endoNF 
(SN1) The carboxyl group of a sialic acid residue functions as acid-catalyst and initialises the hydrolysis of the 
glycosidic linkage. (B) Concerted (SN2) reaction with general base catalysis of the conserved glutamic acid. 
 
Even though the detectable catalytic activity of the mutant Glu581Ala might argue against the 
role of this residue as general base and put forward the substrate assisted SN1 mechanism, 
none of the described potential mechanisms can be ruled out. For a more detailed view on the 
enzymatic mechanism of endoNF additional kinetic and NMR-based studies are necessary. 
Valuable information could also be gained by a crystal structure of endoNF with bound 
active-site ligand. Soaking and cocrystallization experiments with the exosialidase inhibitor 
DANA were not successful so far, but a variety of sialidase inhibitors are available that can be 
testes for inhibitory effect on endoNF and used as crystallization ligands.   
The modular architecture of endoNF impressively reflects the evolution of this mutidomain 
enzyme by shuffling whole domains into a new protein context. Structural similarity and 
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presence of the conserved Asp-box motifs suggest a bacterial origin of the endoNF sialidase 
β-propeller. Its functional combination with a β-barrel domain and a triple intertwined spike 
domain, characteristic for bacteriophage tail-fibres, lead to an enzyme with unique and novel 
substrate specificity. As tailspikes are main determinants of the bacteriophage host range, the 
novel polySia degrading tailspike provided the basis for the evolution of a new group of 
bacteriophages, able to infect also protected polySia encapsulated E. coli K1 bacteria.  
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8 Abbreviations 
ABTS  2,2’-Azino-di-(3-ethylenbethiazolin-sulphate) 
AP Alkaline phosphatase 
APS Ammonium peroxidisulphate 
ATP Adenosine triphosphate 
BCA  Bichionic acid 
BCIP  5-Brom-4-chlor-3-indolyl-phosphate 
bp Base pairs 
BSA Bovine serum albumin 
CMP Cytidine 5’-monophosphat 
Da Dalton 
DMEM ‘Dulbecco’s Modified Eagle’s medium’ 
DMF Dimethylformamide 
DMSO Dimethylsulfoxide 
DNA Desoxyribonucleic acid 
DTT Dithiothreito 
EDTA Ethylendiamine-N,N,N’,N’-tetraacetic acid 
ELISA Enzyme linked immono sorbant assay 
endoNE Endoneuraminidase NE 
IPTG Isopropyl-beta-D-thiogalactopyranoside 
kb kilobase 
kDa Kilodalton 
Kdn 2-Keto-3-doexy-D-glycero-D-galacto-nonusosonic acid 
LB Luria-Bertani  
mAb Monoclonal antibody 
MAD Multiwavelength anomalous dispersion 
MES 2-(N-Morpholino)ethanesulphonic acid 
NBT Nitrotetrazolium-blue chloride 
NCAM Neural cell adhesion molelcule 
Neu5Ac 5-N-acetyl-neuraminic acid 
OD Optical density 
PAGE Polyacrylamide gelelectrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PEG Polyethyleneglycol 
PMSF Phenylmethansulfonylflouride 
polySia  Polysialic acid 
POX Peroxidase 
rmsd Root mean square deviation 
RT Room temperature 
SDS Sodium dodecyl-sulphate 
TCA Trichloroacetic acid 
TEMED  N,N,N’,N’-Tetramethyl-ethylendiamin 
TRIS  Tris(hydroxymethyl)-aminomethan) 
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